{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:39:53Z","timestamp":1792687193731,"version":"4.5.0"},"reference-count":284,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["RS-2024-00451538"],"award-info":[{"award-number":["RS-2024-00451538"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12272-026-01631-y","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:30:42Z","timestamp":1791275442000},"page":"1103-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabis in cancer: a review of therapeutic potential, clinical and preclinical status, and legislation"],"prefix":"10.1007","volume":"49","author":[{"given":"Chhitij","family":"Thapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-6076","authenticated-orcid":false,"given":"Sangkil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-2897","authenticated-orcid":false,"given":"Kyung-Soo","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1631_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/15347354221081772","volume":"21","author":"DI Abrams","year":"2022","unstructured":"Abrams DI (2022) Cannabis, cannabinoids and cannabis-based medicines in cancer care. Integr Cancer Ther 21:1\u201311. https:\/\/doi.org\/10.1177\/15347354221081772","journal-title":"Integr Cancer Ther"},{"key":"1631_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jncimonographs\/lgab010","volume":"58","author":"DI Abrams","year":"2021","unstructured":"Abrams DI, Velasco G, Twelves C, Ganju RK, Ganju RK (2021) Cancer treatment: preclinical & clinical. J Natl Cancer Inst Monogr 58:107\u2013113. https:\/\/doi.org\/10.1093\/jncimonographs\/lgab010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1-3","key":"1631_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2013.08.039","volume":"718","author":"B Adinolfi","year":"2013","unstructured":"Adinolfi B, Romanini A, Vanni A, Martinotti E, Chicca A, Fogli S, Nieri P (2013) Anticancer activity of anandamide in human cutaneous melanoma cells. Eur J Pharmacol 718(1\u20133):154\u2013159. https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.039","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1631_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acs.jnatprod.5b00949","volume":"79","author":"O Aizpurua-Olaizola","year":"2016","unstructured":"Aizpurua-Olaizola O, Soydaner U, \u00d6zt\u00fcrk E, Schibano D, Simsir Y, Navarro P, Etxebarria N, Usobiaga A (2016) Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. J Nat Prod 79(2):324\u2013331. https:\/\/doi.org\/10.1021\/acs.jnatprod.5b00949","journal-title":"J Nat Prod"},{"issue":"1","key":"1631_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42238-023-00190-z","volume":"5","author":"DI Akinloye","year":"2023","unstructured":"Akinloye DI, Metibemu DS, Shittu MT, Lawal MA, Olatunji FO, Oyediran MA, Akinloye OA (2023) Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt. J Cannabis Res 5(1):1\u201315. https:\/\/doi.org\/10.1186\/s42238-023-00190-z","journal-title":"J Cannabis Res"},{"issue":"2","key":"1631_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","volume":"22","author":"AT Ali","year":"2023","unstructured":"Ali AT, Al-Ani O, Al-Ani F (2023) Epidemiology and risk factors for ovarian cancer. Prz Menopauzalny 22(2):93\u2013104. https:\/\/doi.org\/10.5114\/pm.2023.128661","journal-title":"Prz Menopauzalny"},{"issue":"1","key":"1631_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules27010156","volume":"27","author":"CF Almeida","year":"2022","unstructured":"Almeida CF, Teixeira N, Correia-da-Silva G, Amaral C (2021) Cannabinoids in breast cancer: differential susceptibility according to subtype. Molecules 27(1):1\u201321. https:\/\/doi.org\/10.3390\/molecules27010156","journal-title":"Molecules"},{"key":"1631_CR8","unstructured":"American Cancer society (2023a) Brain and spinal cord tumors in adults. In: cancer.org. https:\/\/www.cancer.org\/cancer\/types\/brain-spinal-cord-tumors-adults\/about\/key-statistics.html Accessed 20 September 2023"},{"key":"1631_CR9","unstructured":"American Cancer society (2023b) Key statistics for colorectal cancer. In: cancer.org. https:\/\/www.cancer.org\/cancer\/types\/colon-rectal-cancer\/about\/key-statistics.html Accessed 9 September 2023"},{"key":"1631_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejpb.2018.11.020","volume":"134","author":"J Aparicio-Blanco","year":"2019","unstructured":"Aparicio-Blanco J, Sebasti\u00e1n V, Benoit JP, Torres-Su\u00e1rez AI (2019) Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: in vitro screening of critical parameters. Eur J Pharm Biopharm 134:126\u2013137. https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.020","journal-title":"Eur J Pharm Biopharm"},{"key":"1631_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2021.103340","volume":"162","author":"V Aran","year":"2021","unstructured":"Aran V, Devalle S, Meohas W, Heringer M, Caruso AC, Aguiar DP, Duarte MEL, Neto VM (2021) Osteosarcoma, chondrosarcoma and Ewing sarcoma: clinical aspects, biomarker discovery and liquid biopsy. Crit Rev Oncol Hematol 162:1\u201311. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103340","journal-title":"Crit Rev Oncol Hematol"},{"key":"1631_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01481","volume":"10","author":"SR Archie","year":"2019","unstructured":"Archie SR, Cucullo L (2019) Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective. Front Pharmacol 10:1\u201319. https:\/\/doi.org\/10.3389\/fphar.2019.01481","journal-title":"Front Pharmacol"},{"issue":"6","key":"1631_CR13","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/jid.2015.45","volume":"135","author":"JL Armstrong","year":"2015","unstructured":"Armstrong JL, Hill DS, McKee CS, Hernandez-Tiedra S, Lorente M, Lopez-Valero I, Anagnostou ME, Babatunde F, Corazzari M, Redfern CPF, Velasco G, Lovat PE (2015) Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. J Invest Dermatol 135(6):1629\u20131637. https:\/\/doi.org\/10.1038\/jid.2015.45","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1631_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00109-011-0856-x","volume":"90","author":"G Aviello","year":"2012","unstructured":"Aviello G, Romano B, Borrelli F, Capasso R, Gallo L, Piscitelli F, Di Marzo V, Izzo AA (2012) Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl) 90(8):925\u2013934. https:\/\/doi.org\/10.1007\/s00109-011-0856-x","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"1631_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42238-025-00344-1","volume":"7","author":"J Aviram","year":"2025","unstructured":"Aviram J (2025) Medical cannabis in Israel: a comprehensive review of trends and regulations, 2011\u20132025. J Cannabis Res 7(1):1\u201318. https:\/\/doi.org\/10.1186\/s42238-025-00344-1","journal-title":"J Cannabis Res"},{"issue":"7","key":"1631_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26073104","volume":"26","author":"T Ayakannu","year":"2025","unstructured":"Ayakannu T, Taylor AH, Konje JC (2025) Expression, distribution and function of the transient receptor potential vanilloid type 1 (TRPV1) in endometrial cancer. Int J Mol Sci 26(7):1\u201323. https:\/\/doi.org\/10.3390\/ijms26073104","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1631_CR17","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.31557\/apjcp.2019.20.7.2015","volume":"20","author":"N Azamjah","year":"2019","unstructured":"Azamjah N, Soltan-Zadeh Y, Zayeri F (2019) Global trend of breast cancer mortality rate: a 25-year study. Asian Pac J Cancer Prev 20(7):2015\u20132020. https:\/\/doi.org\/10.31557\/apjcp.2019.20.7.2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"1631_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells13030268","volume":"13","author":"A Bachari","year":"2024","unstructured":"Bachari A, Nassar N, Telukutla S, Zomer R, Piva TJ, Mantri N (2024) Evaluating the mechanism of cell death in melanoma induced by the cannabis extract PHEC-66. Cells 13(3):1\u201317. https:\/\/doi.org\/10.3390\/cells13030268","journal-title":"Cells"},{"key":"1631_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13164229","volume":"13","author":"AE B\u0103dil\u0103","year":"2021","unstructured":"B\u0103dil\u0103 AE, R\u0103dulescu DM, Niculescu AG, Grumezescu AM, R\u0103dulescu M, R\u0103dulescu AR (2021) Recent advances in the treatment of bone metastases and primary bone tumors: an up-to-date review. Cancers 13:1\u201327. https:\/\/doi.org\/10.3390\/cancers13164229","journal-title":"Cancers"},{"issue":"8","key":"1631_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14081957","volume":"14","author":"G Bar-Sela","year":"2022","unstructured":"Bar-Sela G, Cohen I, Campisi-Pinto S, Lewitus GM, Oz-Ari L, Jehassi A, Peer A, Turgeman I, Vernicova O, Berman P, Wollner M, Moskovitz M, Meiri D (2022) Correction: Bar-sela et al. Cannabis consumption used by cancer patients during immunotherapy correlates with poor clinical outcome. Cancers 2020, 12, 2447. Cancers (Basel) 14(8):1\u20132. https:\/\/doi.org\/10.3390\/cancers14081957","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1631_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0267420","volume":"18","author":"J Barakji","year":"2023","unstructured":"Barakji J, Korang SK, Feinberg J, Maagaard M, Mathiesen O, Gluud C, Jakobsen JC (2023) Cannabinoids versus placebo for pain: a systematic review with meta-analysis and trial sequential analysis. PLoS ONE 18(1):1\u201326. https:\/\/doi.org\/10.1371\/journal.pone.0267420","journal-title":"PLoS ONE"},{"issue":"1","key":"1631_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25010074","volume":"25","author":"PP Bathula","year":"2023","unstructured":"Bathula PP, Maciver MB (2023) Cannabinoids in treating chemotherapy-induced nausea and vomiting, cancer-associated pain, and tumor growth. Int J Mol Sci 25(1):1\u201312. https:\/\/doi.org\/10.3390\/ijms25010074","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1631_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15101166","volume":"15","author":"A Benedicto","year":"2022","unstructured":"Benedicto A, Arteta B, Duranti A, Alonso-Alconada D (2022) The synthetic cannabinoid URB447 exerts antitumor and antimetastatic effect in melanoma and colon cancer. Pharmaceuticals (Basel) 15(10):1\u201311. https:\/\/doi.org\/10.3390\/ph15101166","journal-title":"Pharmaceuticals (Basel)"},{"key":"1631_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms242316728","volume":"24","author":"B Bietar","year":"2023","unstructured":"Bietar B, Tanner S, Lehmann C (2023) Neuroprotection and beyond: the central role of CB1 and CB2 receptors in stroke recovery. Int J Mol Sci 24:1\u201317. https:\/\/doi.org\/10.3390\/ijms242316728","journal-title":"Int J Mol Sci"},{"key":"1631_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","volume":"157","author":"S Blasco-Benito","year":"2018","unstructured":"Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, Tundidor I, Andradas C, Garc\u00eda-Taboada E, Wade J, Smith S, Guzm\u00e1n M, P\u00e9rez-G\u00f3mez E, Gordon M, S\u00e1ncez C (2018) Appraising the \u201centourage effect\u201d: antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. Biochem Pharmacol 157:285\u2013293. https:\/\/doi.org\/10.1016\/j.bcp.2018.06.025","journal-title":"Biochem Pharmacol"},{"key":"1631_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2016.05.008","volume":"34","author":"MF Boidi","year":"2016","unstructured":"Boidi MF, Queirolo R, Cruz JM (2016) Cannabis consumption patterns among frequent consumers in Uruguay. Int J Drug Policy 34:34\u201340. https:\/\/doi.org\/10.1016\/j.drugpo.2016.05.008","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1631_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40122-021-00344-y","volume":"11","author":"Y Bonomo","year":"2022","unstructured":"Bonomo Y, Norman A, Collins L, O\u2019Neill H, Galettis P, Trinca J, Strauss N, Martin J, Castle D (2022) Pharmacokinetics, safety, and tolerability of a medicinal cannabis formulation in patients with chronic non-cancer pain on long-term high dose opioid analgesia: a pilot study. Pain Ther 11(1):171\u2013189. https:\/\/doi.org\/10.1007\/s40122-021-00344-y","journal-title":"Pain Ther"},{"key":"1631_CR28","doi-asserted-by":"publisher","unstructured":"Boyac\u0131o\u011flu \u00d6, Bilgi\u00e7 E, Varan C, Bilensoy E, Nemutlu E, Sevim D, Kocaefe \u00c7, Korkusuz P (2021) ACPA decreases non-small cell lung cancer line growth through Akt\/PI3K and JNK pathways in vitro. Cell Death Dis 12(1):1\u201314. https:\/\/doi.org\/10.1038\/s41419-020-03274-3","DOI":"10.1038\/s41419-020-03274-3"},{"issue":"6","key":"1631_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10061282","volume":"10","author":"M Braile","year":"2021","unstructured":"Braile M, Marcella S, Marone G, Galdiero R, Varricchi G, Loffredo S (2021) The interplay between the immune and the endocannabinoid systems in cancer. Cells 10(6):1\u201325. https:\/\/doi.org\/10.3390\/cells10061282","journal-title":"Cells"},{"issue":"13","key":"1631_CR30","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1200\/jco.23.02596","volume":"42","author":"IM Braun","year":"2024","unstructured":"Braun IM, Bohlke K, Abrams DI, Anderson H, Balneaves LG, Bar-Sela G, Bowles DW, Chai PR, Damani A, Gupta A, Hallmeyer S, Subbiah IM, Twelves C, Wallace MS, Roeland EJ (2024) Cannabis and cannabinoids in adults with cancer: ASCO guideline. J Clin Oncol 42(13):1575\u20131593. https:\/\/doi.org\/10.1200\/jco.23.02596","journal-title":"J Clin Oncol"},{"issue":"3","key":"1631_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1631_CR32","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","volume":"22","author":"TD Brisbois","year":"2011","unstructured":"Brisbois TD, de Kock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, Chasen M, MacDonald N, Baracos VE, Wismer WV (2011) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22(9):2086\u20132093. https:\/\/doi.org\/10.1093\/annonc\/mdq727","journal-title":"Ann Oncol"},{"issue":"3","key":"1631_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/15321819.2020.1862863","volume":"42","author":"R Burch","year":"2021","unstructured":"Burch R, Mortuza A, Blumenthal E, Mustafa A (2021) Effects of cannabidiol (CBD) on the inhibition of melanoma cells in vitro. J Immunoassay Immunochem 42(3):285\u2013291. https:\/\/doi.org\/10.1080\/15321819.2020.1862863","journal-title":"J Immunoassay Immunochem"},{"issue":"3","key":"1631_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics17030319","volume":"17","author":"DA Caicedo","year":"2025","unstructured":"Caicedo DA, P\u00e9rez-Ma\u00f1\u00e1 C, Farr\u00e9 M, Papaseit E (2025) An overview of the potential for pharmacokinetic interactions between drugs and cannabis products in humans. Pharmaceutics 17(3):1\u201332. https:\/\/doi.org\/10.3390\/pharmaceutics17030319","journal-title":"Pharmaceutics"},{"issue":"13","key":"1631_CR35","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1158\/0008-5472.Can-06-0169","volume":"66","author":"A Carracedo","year":"2006","unstructured":"Carracedo A, Gironella M, Lorente M, Garcia S, Guzm\u00e1n M, Velasco G, Iovanna JL (2006) Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 66(13):6748\u20136755. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-0169","journal-title":"Cancer Res"},{"key":"1631_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.606808","author":"J Carrera","year":"2020","unstructured":"Carrera J, Tomberlin J, Kurtz J, Karakaya E, Bostanciklioglu M, Albayram O (2020) Endocannabinoid signaling for gabaergic-microglia (mis)communication in the brain aging. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.606808","journal-title":"Front Neurosci"},{"key":"1631_CR37","doi-asserted-by":"publisher","unstructured":"Casanova ML, Bl\u00e1zquez C, Mart\u00ednez-Palacio J, Villanueva C, Fern\u00e1ndez-Ace\u00f1ero MJ, Huff man JW, Jorcano JL, Guzm\u00e1n M (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111(1):43\u201350. https:\/\/doi.org\/10.1172\/jci16116","DOI":"10.1172\/jci16116"},{"key":"1631_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7812\/tpp\/19.200","volume":"25","author":"S Chayasirisobhon","year":"2020","unstructured":"Chayasirisobhon S (2020) Mechanisms of action and pharmacokinetics of cannabis. Perm J 25:1\u20133. https:\/\/doi.org\/10.7812\/tpp\/19.200","journal-title":"Perm J"},{"issue":"1","key":"1631_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/or.2015.3973","volume":"34","author":"L Chen","year":"2015","unstructured":"Chen L, Chen H, Li Y, Li L, Qiu Y, Ren J (2015) Endocannabinoid and ceramide levels are altered in patients with colorectal cancer. Oncol Rep 34(1):447\u2013454. https:\/\/doi.org\/10.3892\/or.2015.3973","journal-title":"Oncol Rep"},{"issue":"20","key":"1631_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14205142","volume":"14","author":"V Cherkasova","year":"2022","unstructured":"Cherkasova V, Wang B, Gerasymchuk M, Fiselier A, Kovalchuk O, Kovalchuk I (2022) Use of cannabis and cannabinoids for treatment of cancer. Cancers (Basel) 14(20):1\u201343. https:\/\/doi.org\/10.3390\/cancers14205142","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1631_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11082323","volume":"11","author":"C Christensen","year":"2023","unstructured":"Christensen C, Rose M, Cornett C, Alles\u00f8 M (2023) Decoding the postulated entourage effect of medicinal cannabis: what it is and what it isn\u2019t. Biomedicines 11(8):1\u201325. https:\/\/doi.org\/10.3390\/biomedicines11082323","journal-title":"Biomedicines"},{"issue":"11","key":"1631_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0312851","volume":"19","author":"C Chutoe","year":"2024","unstructured":"Chutoe C, Inson I, Krobthong S, Phueakphud N, Khunluck T, Wongtrakoongate P, Charoenphandhu N, Lertsuwan K (2024) Combinatorial effects of cannabinoid receptor 1 and 2 agonists on characteristics and proteomic alteration in MDA-MB-231 breast cancer cells. PLoS ONE 19(11):1\u201328. https:\/\/doi.org\/10.1371\/journal.pone.0312851","journal-title":"PLoS ONE"},{"issue":"23","key":"1631_CR43","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1158\/1078-0432.Ccr-08-0799","volume":"14","author":"F Cianchi","year":"2008","unstructured":"Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E (2008) Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 14(23):7691\u20137700. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0799","journal-title":"Clin Cancer Res"},{"issue":"19","key":"1631_CR44","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1074\/jbc.M115.712661","volume":"291","author":"CJ Coke","year":"2016","unstructured":"Coke CJ, Scarlett KA, Chetram MA, Jones KJ, Sandifer BJ, Davis AS, Marcus AI, Hinton CV (2016) Simultaneous activation of induced heterodimerization between CXCR4 chemokine receptor and cannabinoid receptor 2 (CB2) reveals a mechanism for regulation of tumor progression. J Biol Chem 291(19):9991\u201310005. https:\/\/doi.org\/10.1074\/jbc.M115.712661","journal-title":"J Biol Chem"},{"issue":"58","key":"1631_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/jncimonographs\/lgab009","volume":"2021","author":"ZD Cooper","year":"2021","unstructured":"Cooper ZD, Abrams DI, Gust S, Salicrup A, Throckmorton DC (2021) Challenges for clinical cannabis and cannabinoid research in the United States. J Natl Cancer Inst Monogr 2021(58):114\u2013122. https:\/\/doi.org\/10.1093\/jncimonographs\/lgab009","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"1631_CR46","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/can.2021.0006","volume":"6","author":"J Corroon","year":"2021","unstructured":"Corroon J (2021) Cannabinol and sleep: separating fact from fiction. Cannabis Cannabinoid Res 6(5):366\u2013371. https:\/\/doi.org\/10.1089\/can.2021.0006","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"1631_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42238-023-00195-8","volume":"5","author":"C Costiniuk","year":"2023","unstructured":"Costiniuk C, MacCallum CA, Boivin M, Rueda S, Lacasse G, Walsh Z, Daeninck PJ, Margolese S, Mandarino E, Deol JK, Sanchez T, Bell AD (2023) Why a distinct medical stream is necessary to support patients using cannabis for medical purposes. J Cannabis Res 5(1):21\u201310. https:\/\/doi.org\/10.1186\/s42238-023-00195-8","journal-title":"J Cannabis Res"},{"issue":"3","key":"1631_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.31887\/DCNS.2020.22.3\/mcrocq","volume":"22","author":"MA Crocq","year":"2020","unstructured":"Crocq MA (2020) History of cannabis and the endocannabinoid system. Dialogues Clin Neurosci 22(3):223\u2013228. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/mcrocq","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"1631_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bcpt.13152","volume":"124","author":"P Damkier","year":"2019","unstructured":"Damkier P, Lassen D, Christensen MMH, Madsen KG, Hellfritzsch M, Potteg\u00e5rd A (2019) Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol 124(1):28\u201331. https:\/\/doi.org\/10.1111\/bcpt.13152","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"1631_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2013.151","volume":"4","author":"I Dando","year":"2013","unstructured":"Dando I, Donadelli M, Costanzo C, Pozza ED, D\u2019Alessandro A, Zolla L, Palmieri M (2013) Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Cell Death Dis 4(6):1\u201310. https:\/\/doi.org\/10.1038\/cddis.2013.151","journal-title":"Cell Death Dis"},{"issue":"3","key":"1631_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.drugalcdep.2013.02.032","volume":"131","author":"E Danenberg","year":"2013","unstructured":"Danenberg E, Sorge LA, Wieniawski W, Elliott S, Amato L, Scholten WK (2013) Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug Alcohol Depend 131(3):175\u2013181. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.02.032","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1631_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.17305\/bjbms.2018.3532","volume":"19","author":"B Dari\u0161","year":"2019","unstructured":"Dari\u0161 B, Tancer Verboten M, Knez \u017d, Ferk P (2019) Cannabinoids in cancer treatment: therapeutic potential and legislation. Bosn J Basic Med Sci 19(1):14\u201323. https:\/\/doi.org\/10.17305\/bjbms.2018.3532","journal-title":"Bosn J Basic Med Sci"},{"issue":"2","key":"1631_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers16020397","volume":"16","author":"A Darwish","year":"2024","unstructured":"Darwish A, Pammer M, Gallyas F Jr., V\u00edgh L, Balogi Z, Juh\u00e1sz K (2024) Emerging lipid targets in glioblastoma. Cancers (Basel) 16(2):1\u201317. https:\/\/doi.org\/10.3390\/cancers16020397","journal-title":"Cancers (Basel)"},{"issue":"7","key":"1631_CR54","doi-asserted-by":"publisher","first-page":"915","DOI":"10.6004\/jnccn.2016.0094","volume":"14","author":"MP Davis","year":"2016","unstructured":"Davis MP (2016) Cannabinoids for symptom management and cancer therapy: the evidence. J Natl Compr Canc Netw 14(7):915\u2013922. https:\/\/doi.org\/10.6004\/jnccn.2016.0094","journal-title":"J Natl Compr Canc Netw"},{"issue":"21","key":"1631_CR55","doi-asserted-by":"publisher","first-page":"21568","DOI":"10.1021\/acsomega.5c00689","volume":"10","author":"FV de Carvalho","year":"2025","unstructured":"de Carvalho FV, Geronimo G, de Moura LD, Mendonca TC, Breitkreitz MC, de Pula E, da Silva GHR (2025) Codelivery of paclitaxel and cannabidiol in lipid nanoparticles enhances cytotoxicity against melanoma cells. ACS Omega 10(21):21568\u201321580. https:\/\/doi.org\/10.1021\/acsomega.5c00689","journal-title":"ACS Omega"},{"key":"1631_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2021.747229","volume":"15","author":"RA de Melo Reis","year":"2021","unstructured":"de Melo Reis RA, Isaac AR, Freitas HR, de Almeida MM, Schuck PF, Ferreira GC, Andrade-da-Costa BL, Trevenzoli IH (2021) Quality of life and a surveillant endocannabinoid system. Front Neurosci 15:1\u201328. https:\/\/doi.org\/10.3389\/fnins.2021.747229","journal-title":"Front Neurosci"},{"issue":"1","key":"1631_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","volume":"168","author":"L De Petrocellis","year":"2013","unstructured":"De Petrocellis L, Ligresti A, Schiano Moriello A, Iappelli M, Verde R, Stott CG, Cristino L, Orlando P, Di Marzo V (2013) Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol 168(1):79\u2013102. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02027.x","journal-title":"Br J Pharmacol"},{"key":"1631_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ani15152185","volume":"15","author":"G della Rocca","year":"2025","unstructured":"della Rocca G, Di Salvo A, Salucci E, Amadori M, Re G, Vercelli C (2025) The role of the endocannabinoid system in oncology and the potential use of cannabis derivatives for cancer management in companion animals. Animals 15:1\u201321. https:\/\/doi.org\/10.3390\/ani15152185","journal-title":"Animals"},{"issue":"6","key":"1631_CR59","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1152\/ajpgi.90455.2008","volume":"295","author":"S DeMorrow","year":"2008","unstructured":"DeMorrow S, Francis H, Gaudio E, Venter J, Franchitto A, Kopriva S, Onori P, Mancinelli R, Frampton G, Coufal M, Mitchell B, Vaculin B, Alpini G (2008) The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol 295(6):1150\u20131158. https:\/\/doi.org\/10.1152\/ajpgi.90455.2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"1631_CR60","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","volume":"10","author":"H Deng","year":"2020","unstructured":"Deng H, Li W (2020) Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. Acta Pharm Sin B 10(4):582\u2013602. https:\/\/doi.org\/10.1016\/j.apsb.2019.10.006","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"1631_CR61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1503\/jpn.240049","volume":"49","author":"P Di Ciano","year":"2024","unstructured":"Di Ciano P, Wickens C, Paul EM, Mahmood R, Cr\u00e9pault JF, Rueda S, Boileau I (2024) The Cannabis Act: implications for human participant research with cannabis. J Psychiatry Neurosci 49(3):212\u2013217. https:\/\/doi.org\/10.1503\/jpn.240049","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"1631_CR62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2020.22.3\/vdimarzo","volume":"22","author":"V Di Marzo","year":"2020","unstructured":"Di Marzo V (2020) The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders. Dialogues Clin Neurosci 22(3):259\u2013269. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/vdimarzo","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"1631_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12030525","volume":"12","author":"L Dobovi\u0161ek","year":"2020","unstructured":"Dobovi\u0161ek L, Krstanovi\u0107 F, Bor\u0161tnar S, Debeljak N (2020) Cannabinoids and hormone receptor-positive breast cancer treatment. Cancers (Basel) 12(3):1\u201312. https:\/\/doi.org\/10.3390\/cancers12030525","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1631_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2011.36","volume":"2","author":"M Donadelli","year":"2011","unstructured":"Donadelli M, Dando I, Zaniboni T, Costanzo C, Pozza ED, Scupoli MT, Scarpa A, Zappavigna S, Marra M, Abbruzzese A, Bifulco M, Caraglia M, Palmieri M (2011) Gemcitabine\/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis 2(4):1\u201312. https:\/\/doi.org\/10.1038\/cddis.2011.36","journal-title":"Cell Death Dis"},{"key":"1631_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03870-3","author":"M Esmaeli","year":"2025","unstructured":"Esmaeli M, Dehghanpour Dehabadi M (2025) Cannabidiol (CBD) as a potential therapeutic agent for liver cancer: a comprehensive review of current evidence. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-025-03870-3","journal-title":"Cancer Cell Int"},{"key":"1631_CR66","unstructured":"European Medicines Agency (2006) Guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin. In: EMA. https:\/\/www.ema.europa.eu\/en\/good-agricultural-collection-practice-starting-materials-herbal-origin-scientific-guideline Accessed 9 September 2023"},{"issue":"7","key":"1631_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11071922","volume":"11","author":"PA Everts","year":"2023","unstructured":"Everts PA, Lana JF, Onishi K, Buford D, Peng J, Mahmood A, Fonseca LF, Zundert AV, Podesta L (2023) Angiogenesis and tissue repair depend on platelet dosing and bioformulation strategies following orthobiological platelet-rich plasma procedures: a narrative review. Biomedicines 11(7):1\u201329. https:\/\/doi.org\/10.3390\/biomedicines11071922","journal-title":"Biomedicines"},{"issue":"3","key":"1631_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/ajpendo.00210.2020","volume":"319","author":"HC Ezechukwu","year":"2020","unstructured":"Ezechukwu HC, Diya CA, Shrestha N, Hryciw DH (2020) Role for endocannabinoids in early pregnancy: recent advances and the effects of cannabis use. Am J Physiol Endocrinol Metab 319(3):1\u20135. https:\/\/doi.org\/10.1152\/ajpendo.00210.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1631_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2049463717710042","volume":"11","author":"MT Fallon","year":"2017","unstructured":"Fallon MT, Albert Lux E, McQuade R, Rossetti S, Sanchez R, Sun W, Wright S, Lichtman AL, Kornyeyeva E (2017) Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies. Br J Pain 11(3):119\u2013133. https:\/\/doi.org\/10.1177\/2049463717710042","journal-title":"Br J Pain"},{"issue":"6","key":"1631_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph19063174","volume":"19","author":"N Fearby","year":"2022","unstructured":"Fearby N, Penman S, Thanos P (2022) Effects of \u03949-Tetrahydrocannibinol (THC) on obesity at different stages of life: a literature review. Int J Environ Res Public Health 19(6):1\u201328. https:\/\/doi.org\/10.3390\/ijerph19063174","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"1631_CR71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0036-1586146","volume":"33","author":"P Filippou","year":"2016","unstructured":"Filippou P, Ferguson JE 3rd, Nielsen ME (2016) Epidemiology of prostate and testicular cancer. Semin Intervent Radiol 33(3):182\u2013185. https:\/\/doi.org\/10.1055\/s-0036-1586146","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"1631_CR72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13105-018-0611-7","volume":"74","author":"BM Fonseca","year":"2018","unstructured":"Fonseca BM, Correia-da-Silva G, Teixeira NA (2018) Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. J Physiol Biochem 74(2):261\u2013272. https:\/\/doi.org\/10.1007\/s13105-018-0611-7","journal-title":"J Physiol Biochem"},{"key":"1631_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2025.1599012","volume":"16","author":"CDF Fonseca","year":"2025","unstructured":"Fonseca CDF, Zendulka O, Ju\u0159ica J (2025) Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review. Front Pharmacol 16:1\u201313. https:\/\/doi.org\/10.3389\/fphar.2025.1599012","journal-title":"Front Pharmacol"},{"key":"1631_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26115173","volume":"26","author":"A Forma","year":"2025","unstructured":"Forma A, K\u0142odnicka K, Paj\u0105k W, Flieger J (2025) Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies. Int J Mol Sci 26:1\u201344. https:\/\/doi.org\/10.3390\/ijms26115173","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1631_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1163\/15718093-bja10060","volume":"29","author":"F Forni","year":"2022","unstructured":"Forni F (2022) Free movement of medicines and protection of public health. Eur J Health Law 29(2):217\u2013239. https:\/\/doi.org\/10.1163\/15718093-bja10060","journal-title":"Eur J Health Law"},{"key":"1631_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.118916","volume":"574","author":"AI Fraguas-S\u00e1nchez","year":"2020","unstructured":"Fraguas-S\u00e1nchez AI, Fern\u00e1ndez-Carballido A, Simancas-Herbada R, Martin-Sabroso C, Torres-Su\u00e1rez AI (2020a) CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer. Int J Pharm 574:1\u201339. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118916","journal-title":"Int J Pharm"},{"issue":"5","key":"1631_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12050439","volume":"12","author":"AI Fraguas-S\u00e1nchez","year":"2020","unstructured":"Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI, Cohen M, Delie F, Bastida-Ruiz D, Yart L, Martin-Sabroso C, Fern\u00e1ndez-Carballido A (2020b) PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: in vitro and in ovo assessment. Pharmaceutics 12(5):1\u20139. https:\/\/doi.org\/10.3390\/pharmaceutics12050439","journal-title":"Pharmaceutics"},{"key":"1631_CR78","doi-asserted-by":"publisher","unstructured":"Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI, Cohen M, Delie F, Bastida-Ruiz D, Yart L, Martin-Sabroso C, Fern\u00e1ndez-Carballido A (2020c) PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: in vitro and in ovo assessment. Pharmaceutics 12(5):1\u201329. https:\/\/doi.org\/10.3390\/pharmaceutics12050439","DOI":"10.3390\/pharmaceutics12050439"},{"key":"1631_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2020.108442","volume":"185","author":"V Franco","year":"2021","unstructured":"Franco V, Bialer M, Perucca E (2021) Cannabidiol in the treatment of epilepsy: current evidence and perspectives for further research. Neuropharmacology 185:1\u20138. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108442","journal-title":"Neuropharmacology"},{"issue":"1","key":"1631_CR80","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1871529x18666180206161457","volume":"18","author":"ML Fulmer","year":"2018","unstructured":"Fulmer ML, Thewke DP (2018) The endocannabinoid system and heart disease: the role of cannabinoid receptor type 2. Cardiovasc Hematol Disord Drug Targets 18(1):34\u201351. https:\/\/doi.org\/10.2174\/1871529x18666180206161457","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"6","key":"1631_CR81","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1310\/hpj4806-473","volume":"48","author":"M Gabay","year":"2013","unstructured":"Gabay M (2013) The federal controlled substances act: schedules and pharmacy registration. Hosp Pharm 48(6):473\u2013474. https:\/\/doi.org\/10.1310\/hpj4806-473","journal-title":"Hosp Pharm"},{"issue":"2","key":"1631_CR82","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jdermsci.2015.11.005","volume":"81","author":"A G\u0119gotek","year":"2016","unstructured":"G\u0119gotek A, Biernacki M, Ambro\u017cewicz E, Sura\u017cy\u0144ski A, Wro\u0144ski A, Skrzydlewska E (2016) The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation. J Dermatol Sci 81(2):107\u2013117. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.11.005","journal-title":"J Dermatol Sci"},{"issue":"3","key":"1631_CR83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1476-5381.2010.00745.x","volume":"160","author":"J Gertsch","year":"2010","unstructured":"Gertsch J, Pertwee RG, Di Marzo V (2010) Phytocannabinoids beyond the cannabis plant - do they exist? Br J Pharmacol 160(3):523\u2013529. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00745.x","journal-title":"Br J Pharmacol"},{"issue":"21","key":"1631_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15215152","volume":"15","author":"L Giannella","year":"2023","unstructured":"Giannella L, Ciavattini A (2023) Screening and early diagnosis in gynecological cancers. Cancers (Basel) 15(21):1\u20135. https:\/\/doi.org\/10.3390\/cancers15215152","journal-title":"Cancers (Basel)"},{"key":"1631_CR85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lfs.2015.04.003","volume":"138","author":"N Glodde","year":"2015","unstructured":"Glodde N, Jakobs M, Bald T, T\u00fcting T, Gaffal E (2015) Differential role of cannabinoids in the pathogenesis of skin cancer. Life Sci 138:35\u201340. https:\/\/doi.org\/10.1016\/j.lfs.2015.04.003","journal-title":"Life Sci"},{"issue":"1","key":"1631_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-77674-y","volume":"10","author":"YY Go","year":"2020","unstructured":"Go YY, Kim SR, Kim DY, Chae SW, Song JJ (2020) Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep 10(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-020-77674-y","journal-title":"Sci Rep"},{"issue":"5","key":"1631_CR87","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/cpt.3381","volume":"116","author":"AA Gorbenko","year":"2024","unstructured":"Gorbenko AA, Heuberger J, Klumpers LE, de Kam ML, Strugala PK, de Visser SJ, Groeneveld GJ (2024) Cannabidiol increases psychotropic effects and plasma concentrations of \u0394(9)-tetrahydrocannabinol without improving its analgesic properties. Clin Pharmacol Ther 116(5):1289\u20131303. https:\/\/doi.org\/10.1002\/cpt.3381","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1631_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43043-024-00184-8","volume":"29","author":"A Govahi","year":"2024","unstructured":"Govahi A, Eghbali S, Ajdary M, Amjadi F, Nazari M, Kazorgah FM, Mehdizadeh M (2024) Cannabidiol impairs sperm quality and function in adult mice. Middle East Fertil Soc J 29(1):1\u20139. https:\/\/doi.org\/10.1186\/s43043-024-00184-8","journal-title":"Middle East Fertil Soc J"},{"key":"1631_CR89","unstructured":"Government of Canada (2024) Cannabis for medical purposes under the Cannabis Act: information and improvements. In. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/medical-use-cannabis.html#_Access_to_cannabis Accessed 11 November 2025"},{"issue":"1","key":"1631_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2024.57069","volume":"8","author":"JL Gowin","year":"2025","unstructured":"Gowin JL, Ellingson JM, Karoly HC, Manza P, Ross JM, Sloan ME, Tanabe JL, Volkow ND (2025) Brain function outcomes of recent and lifetime cannabis use. JAMA Netw Open 8(1):1\u201314. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.57069","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1631_CR91","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.21037\/jtd.2017.06.104","volume":"9","author":"H Goyal","year":"2017","unstructured":"Goyal H, Awad HH, Ghali JK (2017) Role of cannabis in cardiovascular disorders. J Thorac Dis 9(7):2079\u20132092. https:\/\/doi.org\/10.21037\/jtd.2017.06.104","journal-title":"J Thorac Dis"},{"issue":"1","key":"1631_CR92","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/can.2017.0015","volume":"2","author":"U Grabiec","year":"2017","unstructured":"Grabiec U, Dehghani F (2017) N-arachidonoyl dopamine: a novel endocannabinoid and endovanilloid with widespread physiological and pharmacological activities. Cannabis Cannabinoid Res 2(1):183\u2013196. https:\/\/doi.org\/10.1089\/can.2017.0015","journal-title":"Cannabis Cannabinoid Res"},{"key":"1631_CR93","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2018.10.030","volume":"291","author":"K Greish","year":"2018","unstructured":"Greish K, Mathur A, Al Zahrani R, Elkaissi S, Al Jishi M, Nazzal O, Taha S, Pittal\u00e0 V, Taurin S (2018) Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer. J Control Release 291:184\u2013195. https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.030","journal-title":"J Control Release"},{"issue":"1","key":"1631_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-022-02843-0","volume":"23","author":"T Gromowski","year":"2023","unstructured":"Gromowski T, Lukacs-Kornek V, Cisowski J (2023) Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination. Cancer Cell Int 23(1):1\u201319. https:\/\/doi.org\/10.1186\/s12935-022-02843-0","journal-title":"Cancer Cell Int"},{"key":"1631_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02288","volume":"10","author":"Z Gu","year":"2019","unstructured":"Gu Z, Singh S, Niyogi RG, Lamont GJ, Wang H, Lamont RJ, Scott DA (2019) Marijuana-derived cannabinoids trigger a CB2\/PI3K axis of suppression of the innate response to oral pathogens. Front Immunol 10:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2019.02288","journal-title":"Front Immunol"},{"issue":"2","key":"1631_CR96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","volume":"95","author":"M Guzm\u00e1n","year":"2006","unstructured":"Guzm\u00e1n M, Duarte MJ, Bl\u00e1zquez C, Ravina J, Rosa MC, Galve-Roperh I, S\u00e1nchez C, Velasco G, Gonz\u00e1lez-Feria L (2006) A pilot clinical study of delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 95(2):197\u2013203. https:\/\/doi.org\/10.1038\/sj.bjc.6603236","journal-title":"Br J Cancer"},{"issue":"1-2","key":"1631_CR97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2011.10.011","volume":"353","author":"P Gyombolai","year":"2012","unstructured":"Gyombolai P, Pap D, Turu G, Catt KJ, Bagdy G, Hunyady L (2012) Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action. Mol Cell Endocrinol 353(1\u20132):29\u201336. https:\/\/doi.org\/10.1016\/j.mce.2011.10.011","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1631_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cts.13685","volume":"17","author":"JS Hansen","year":"2024","unstructured":"Hansen JS, Boix F, Hasselstr\u00f8m JB, S\u00f8rensen LK, Kjolby M, Gustavsen S, Hansen RM, Petersen T, Sellebjerg F, Kasch H, Rasmussen PV, Finnerup NB, Saedder EA, Svendsen KB (2024) Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial. Clin Transl Sci 17(1):1\u201314. https:\/\/doi.org\/10.1111\/cts.13685","journal-title":"Clin Transl Sci"},{"issue":"6","key":"1631_CR99","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-03-3720","volume":"64","author":"S Hart","year":"2004","unstructured":"Hart S, Fischer OM, Ullrich A (2004) Cannabinoids induce cancer cell proliferation via tumor necrosis factor \u03b1-converting enzyme (TACE\/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res 64(6):1943\u20131950. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-3720","journal-title":"Cancer Res"},{"key":"1631_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.702675","volume":"12","author":"HM Hashiesh","year":"2021","unstructured":"Hashiesh HM, Sharma C, Goyal SN, Jha NK, Ojha S (2021) Pharmacological properties, therapeutic potential and molecular mechanisms of JWH133, a CB2 receptor-selective agonist. Front Pharmacol 12:1\u201334. https:\/\/doi.org\/10.3389\/fphar.2021.702675","journal-title":"Front Pharmacol"},{"issue":"2","key":"1631_CR101","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bcp.2014.07.014","volume":"92","author":"M Haustein","year":"2014","unstructured":"Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B (2014) Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1. Biochem Pharmacol 92(2):312\u2013325. https:\/\/doi.org\/10.1016\/j.bcp.2014.07.014","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1631_CR102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.siny.2019.02.001","volume":"24","author":"P Henschke","year":"2019","unstructured":"Henschke P (2019) Cannabis: an ancient friend or foe? What works and doesn\u2019t work. Semin Fetal Neonatal Med 24(2):149\u2013154. https:\/\/doi.org\/10.1016\/j.siny.2019.02.001","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3\u20134","key":"1631_CR103","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10555-011-9318-8","volume":"30","author":"DJ Hermanson","year":"2011","unstructured":"Hermanson DJ, Marnett LJ (2011) Cannabinoids, endocannabinoids, and cancer. Cancer Metastasis Rev 30(3\u20134):599\u2013612. https:\/\/doi.org\/10.1007\/s10555-011-9318-8","journal-title":"Cancer Metastasis Rev"},{"key":"1631_CR104","doi-asserted-by":"publisher","unstructured":"Hern\u00e1n P\u00e9rez de la Ossa D, Lorente M, Gil-Alegre ME, Torres S, Garc\u00eda-Taboada E, Aberturas Mdel R, Molpeceres J, Velasco G, Torres-Su\u00e1rez AI (2013) Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. PLoS One 8(1):1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0054795","DOI":"10.1371\/journal.pone.0054795"},{"issue":"10","key":"1631_CR105","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/bph.14426","volume":"176","author":"B Hinz","year":"2019","unstructured":"Hinz B, Ramer R (2019) Anti-tumour actions of cannabinoids. Br J Pharmacol 176(10):1384\u20131394. https:\/\/doi.org\/10.1111\/bph.14426","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1631_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41416-022-01727-4","volume":"127","author":"B Hinz","year":"2022","unstructured":"Hinz B, Ramer R (2022) Cannabinoids as anticancer drugs: current status of preclinical research. Br J Cancer 127(1):1\u201313. https:\/\/doi.org\/10.1038\/s41416-022-01727-4","journal-title":"Br J Cancer"},{"issue":"10","key":"1631_CR107","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1503\/cmaj.160369","volume":"188","author":"SJ Hoffman","year":"2016","unstructured":"Hoffman SJ, Habibi R (2016) International legal barriers to Canada\u2019s marijuana plans. CMAJ 188(10):215\u2013216. https:\/\/doi.org\/10.1503\/cmaj.160369","journal-title":"CMAJ"},{"issue":"19","key":"1631_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms241914514","volume":"24","author":"KR Hossain","year":"2023","unstructured":"Hossain KR, Alghalayini A, Valenzuela SM (2023) Current challenges and opportunities for improved cannabidiol solubility. Int J Mol Sci 24(19):1\u201315. https:\/\/doi.org\/10.3390\/ijms241914514","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1631_CR109","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/labinvest.2011.62","volume":"91","author":"L Huang","year":"2011","unstructured":"Huang L, Ramirez JC, Frampton GA, Golden LE, Quinn MA, Pae HY, Horvat D, Liang L, DeMorrow S (2011) Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. Lab Invest 91(7):1007\u201310017. https:\/\/doi.org\/10.1038\/labinvest.2011.62","journal-title":"Lab Invest"},{"issue":"11","key":"1631_CR110","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1080\/15548627.2021.1885203","volume":"17","author":"T Huang","year":"2021","unstructured":"Huang T, Xu T, Wang Y, Zhou Y, Yu D, Wang Z, He L, Chen Z, Zhang Y, Davidson D, Dai Y, Hang C, Liu X, Yan C (2021) Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. Autophagy 17(11):3592\u20133606. https:\/\/doi.org\/10.1080\/15548627.2021.1885203","journal-title":"Autophagy"},{"issue":"44","key":"1631_CR111","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1523\/jneurosci.0708-19.2019","volume":"39","author":"R Hudson","year":"2019","unstructured":"Hudson R, Renard J, Norris C, Rushlow WJ, Laviolette SR (2019) Cannabidiol counteracts the psychotropic side-effects of \u0394-9-tetrahydrocannabinol in the ventral hippocampus through bidirectional control of ERK1-2 phosphorylation. J Neurosci 39(44):8762\u20138777. https:\/\/doi.org\/10.1523\/jneurosci.0708-19.2019","journal-title":"J Neurosci"},{"issue":"9","key":"1631_CR112","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1007\/s00044-014-0972-6","volume":"23","author":"AS Husni","year":"2014","unstructured":"Husni AS, McCurdy CR, Radwan MM, Ahmed SA, Slade D, Ross SA, ElSohly MA, Cutler SJ (2014) Evaluation of phytocannabinoids from high potency Cannabis sativa using in vitro bioassays to determine structure-activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2. Med Chem Res 23(9):4295\u20134300. https:\/\/doi.org\/10.1007\/s00044-014-0972-6","journal-title":"Med Chem Res"},{"key":"1631_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mtsust.2025.101153","volume":"31","author":"A Jakhmola","year":"2025","unstructured":"Jakhmola A, Kashkooli FM, Rod K, Lodyga M, Tavakkoli J, Kolios MC (2025) Green synthesis of cannabinoids loaded gold nanoparticles displaying enhanced anti-cancer properties. Mater Today Sustain 31:1\u201316. https:\/\/doi.org\/10.1016\/j.mtsust.2025.101153","journal-title":"Mater Today Sustain"},{"issue":"1","key":"1631_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-024-00590-7","volume":"19","author":"K Javadi","year":"2024","unstructured":"Javadi K, Ferdosi-Shahandashti E, Rajabnia M, Khaledi M (2024) Vaginal microbiota and gynecological cancers: a complex and evolving relationship. Infect Agent Cancer 19(1):1\u201312. https:\/\/doi.org\/10.1186\/s13027-024-00590-7","journal-title":"Infect Agent Cancer"},{"key":"1631_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2016.02.010","volume":"775","author":"FA Javid","year":"2016","unstructured":"Javid FA, Phillips RM, Afshinjavid S, Verde R, Ligresti A (2016) Cannabinoid pharmacology in cancer research: a new hope for cancer patients? Eur J Pharmacol 775:1\u201314. https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.010","journal-title":"Eur J Pharmacol"},{"key":"1631_CR116","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2019.01.011","volume":"447","author":"S Jeong","year":"2019","unstructured":"Jeong S, Yun HK, Jeong YA, Jo MJ, Kang SH, Kim JL, Kim DY, Park SH, Kim BR, Na YJ, Lee SL, Kim HD, Kim DH, Oh SC, Lee DH (2019) Cannabidiol-induced apoptosis is mediated by activation of noxa in human colorectal cancer cells. Cancer Lett 447:12\u201323. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.011","journal-title":"Cancer Lett"},{"issue":"1","key":"1631_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-93264-y","volume":"11","author":"S Jerushalmi","year":"2021","unstructured":"Jerushalmi S, Maymon M, Dombrovsky A, Regev R, Schmilovitch Z, Namdar D, Shalev N, Koltai H, Freeman S (2021) Effects of steam sterilization on reduction of fungal colony forming units, cannabinoids and terpene levels in medical cannabis inflorescences. Sci Rep 11(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-021-93264-y","journal-title":"Sci Rep"},{"issue":"1","key":"1631_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26010078","volume":"26","author":"V Jha","year":"2020","unstructured":"Jha V, Biagi M, Spinelli V, Di Stefano M, Macchia M, Minutolo F, Granchi C, Poli G, Tuccinardi T (2020) Discovery of monoacylglycerol lipase (MAGL) inhibitors based on a pharmacophore-guided virtual screening study. Molecules 26(1):1\u201313. https:\/\/doi.org\/10.3390\/molecules26010078","journal-title":"Molecules"},{"issue":"21","key":"1631_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25214930","volume":"25","author":"\u00c9 Jones","year":"2020","unstructured":"Jones \u00c9, Vlachou S (2020) A critical review of the role of the cannabinoid compounds \u0394(9)-tetrahydrocannabinol (\u0394(9)-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment. Molecules 25(21):1\u201320. https:\/\/doi.org\/10.3390\/molecules25214930","journal-title":"Molecules"},{"issue":"32","key":"1631_CR120","doi-asserted-by":"publisher","first-page":"52364","DOI":"10.18632\/oncotarget.10564","volume":"7","author":"M Jov\u00e9","year":"2016","unstructured":"Jov\u00e9 M, Gatius S, Yeramian A, Portero-Otin M, Eritja N, Santacana M, Colas E, Ruiz M, Pamplona R, Matias-Guiu X (2016) Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism. Oncotarget 7(32):52364\u201352374. https:\/\/doi.org\/10.18632\/oncotarget.10564","journal-title":"Oncotarget"},{"key":"1631_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26157095","volume":"26","author":"P Kalak","year":"2025","unstructured":"Kalak P, Kupczyk P, Szumny A, G\u0119barowski T, Jasiak M, Nied\u017awied\u017a A, Ni\u017ca\u0144ski W, Dzi\u0119cio\u0142 M (2025) Molecular mechanisms of the endocannabinoid system with a focus on reproductive physiology and the cannabinoid impact on fertility. Int J Mol Sci 26:1\u201333. https:\/\/doi.org\/10.3390\/ijms26157095","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1631_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics15020554","volume":"15","author":"AK Kalvala","year":"2023","unstructured":"Kalvala AK, Bagde A, Arthur P, Kulkarni T, Bhattacharya S, Surapaneni S, Patel NK, Nimma R, Gebeyehu A, Kommineni N, Li Y, Meckes DG, Sun L, Banjara B, Kellum K, Dinh TC, Singh M (2023) Cannabidiol-loaded extracellular vesicles from human umbilical cord mesenchymal stem cells alleviate paclitaxel-induced peripheral neuropathy. Pharmaceutics 15(9):1\u201324. https:\/\/doi.org\/10.3390\/pharmaceutics15020554","journal-title":"Pharmaceutics"},{"issue":"10","key":"1631_CR123","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.21873\/anticanres.12924","volume":"38","author":"J Kenyon","year":"2018","unstructured":"Kenyon J, Liu W, Dalgleish A (2018) Report of objective clinical responses of cancer patients to pharmaceutical-grade synthetic cannabidiol. Anticancer Res 38(10):5831\u20135835. https:\/\/doi.org\/10.21873\/anticanres.12924","journal-title":"Anticancer Res"},{"issue":"44","key":"1631_CR124","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1523\/jneurosci.2847-08.2008","volume":"28","author":"IA Khasabova","year":"2008","unstructured":"Khasabova IA, Khasabov SG, Harding-Rose C, Coicou LG, Seybold BA, Lindberg AE, Steevens CD, Simone DA, Seybold VS (2008) A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. J Neurosci 28(44):11141\u201311152. https:\/\/doi.org\/10.1523\/jneurosci.2847-08.2008","journal-title":"J Neurosci"},{"key":"1631_CR125","doi-asserted-by":"publisher","first-page":"35","DOI":"10.46570\/utjms.vol6-2019-339","volume":"6","author":"R Kheireldin","year":"2019","unstructured":"Kheireldina R (2019) A case report of clobazam toxicity related to cannabidiol and clobazam drug-drug interaction. Transl (UT) J Med Sci 6:35\u201336. https:\/\/doi.org\/10.46570\/utjms.vol6-2019-339","journal-title":"Transl. (UT) J. Med. Sci."},{"issue":"7","key":"1631_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20071673","volume":"20","author":"T Kiskov\u00e1","year":"2019","unstructured":"Kiskov\u00e1 T, Mungenast F, Suv\u00e1kov\u00e1 M, J\u00e4ger W, Thalhammer T (2019) Future aspects for cannabinoids in breast cancer therapy. Int J Mol Sci 20(7):1\u201321. https:\/\/doi.org\/10.3390\/ijms20071673","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1631_CR127","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.Epi-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB (2022) Epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev 31(7):1284\u20131297. https:\/\/doi.org\/10.1158\/1055-9965.Epi-21-1440","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"1631_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13051064","volume":"13","author":"MR Kolbe","year":"2021","unstructured":"Kolbe MR, Hohmann T, Hohmann U, Ghadban C, Mackie K, Z\u00f6ller C, Prell J, Illert J, Strauss C, Dehghani F (2021) THC reduces Ki67-immunoreactive cells derived from human primary glioblastoma in a GPR55-dependent manner. Cancers (Basel) 13(5):1\u201321. https:\/\/doi.org\/10.3390\/cancers13051064","journal-title":"Cancers (Basel)"},{"key":"1631_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.699951","volume":"12","author":"ML Kozakiewicz","year":"2021","unstructured":"Kozakiewicz ML, Grotegut CA, Howlett AC (2021) Endocannabinoid system in pregnancy maintenance and labor: a mini-review. Front Endocrinol (Lausanne) 12:1\u20137. https:\/\/doi.org\/10.3389\/fendo.2021.699951","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1631_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbcan.2023.189054","volume":"1","author":"M Kusaczuk","year":"1879","unstructured":"Kusaczuk M, Ambel ET, Naumowicz M, Velasco G (2024) Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma. Biochim Biophys Acta Rev Cancer 1:1\u201321. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189054","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"23","key":"1631_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms242316621","volume":"24","author":"IS Kwon","year":"2023","unstructured":"Kwon IS, Hwang YN, Park JH, Na HH, Kwon T, Park JS, Kim KC (2023) Metallothionein family proteins as regulators of zinc ions synergistically enhance the anticancer effect of cannabidiol in human colorectal cancer cells. Int J Mol Sci 24(23):1\u201316. https:\/\/doi.org\/10.3390\/ijms242316621","journal-title":"Int J Mol Sci"},{"key":"1631_CR132","unstructured":"L\u2019Heureux M (2018) South Korea legalizes medical cannabis. In. https:\/\/www.cannabissciencetech.com\/view\/south-korea-legalizes-medical-cannabis Accessed 11 Nov. 2025"},{"issue":"16","key":"1631_CR133","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1016\/j.ejca.2012.02.062","volume":"48","author":"C Laezza","year":"2012","unstructured":"Laezza C, D\u2019Alessandro A, Paladino S, Malfitano AM, Proto MC, Gazzerro P, Pisanti S, Santoro A, Ciaglia E, Bifulco M (2012) Anandamide inhibits the Wnt\/\u03b2-catenin signalling pathway in human breast cancer MDA MB 231 cells. Eur J Cancer 48(16):3112\u20133122. https:\/\/doi.org\/10.1016\/j.ejca.2012.02.062","journal-title":"Eur J Cancer"},{"key":"1631_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21030747","volume":"21","author":"C Laezza","year":"2020","unstructured":"Laezza C, Pagano C, Navarra G, Pastorino O, Proto MC, Fiore D, Piscopo C, Gazzerro P, Bifulco M (2020) The endocannabinoid system: a target for cancer treatment. Int J Mol Sci 21:1\u201321. https:\/\/doi.org\/10.3390\/ijms21030747","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1631_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22031001","volume":"22","author":"A Lago-Fernandez","year":"2021","unstructured":"Lago-Fernandez A, Zarzo-Arias S, Jagerovic N, Morales P (2021) Relevance of peroxisome proliferator activated receptors in multitarget paradigm associated with the endocannabinoid system. Int J Mol Sci 22(3):1\u201328. https:\/\/doi.org\/10.3390\/ijms22031001","journal-title":"Int J Mol Sci"},{"key":"1631_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/839403","volume":"2015","author":"E Lakiotaki","year":"2015","unstructured":"Lakiotaki E, Giaginis C, Tolia M, Alexandrou P, Delladetsima I, Giannopoulou I, Kyrgias G, Patsouris E, Theocharis S (2015) Clinical significance of cannabinoid receptors CB1 and CB2 expression in human malignant and benign thyroid lesions. Biomed Res Int 2015:1\u20137. https:\/\/doi.org\/10.1155\/2015\/839403","journal-title":"Biomed Res Int"},{"key":"1631_CR137","unstructured":"Lamers M (2018) South Korea legislature passes medical cannabis law, first in East Asia. In. https:\/\/mjbizdaily.com\/breaking-south-korea-becomes-first-country-in-east-asia-to-legalize-medical-cannabis\/ Accessed Nov 11, 2025"},{"issue":"2","key":"1631_CR138","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/cpt.563","volume":"101","author":"R Le Boisselier","year":"2017","unstructured":"Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D (2017) Focus on cannabinoids and synthetic cannabinoids. Clin Pharmacol Ther 101(2):220\u2013229. https:\/\/doi.org\/10.1002\/cpt.563","journal-title":"Clin Pharmacol Ther"},{"key":"1631_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6477132","volume":"2022","author":"S Leelawat","year":"2022","unstructured":"Leelawat S, Leelawat K, Yimsoo T, Wunnakup T, Monton C, Khamthong N, Madaka F, Maha A, Songsak T (2022) Antitumor effects of delta (9)-tetrahydrocannabinol and cannabinol on cholangiocarcinoma cells and xenograft mouse models. Evid Based Complement Alternat Med 2022:1\u201314. https:\/\/doi.org\/10.1155\/2022\/6477132","journal-title":"Evid Based Complement Alternat Med"},{"issue":"10","key":"1631_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11102630","volume":"11","author":"ZJ Leinen","year":"2023","unstructured":"Leinen ZJ, Mohan R, Premadasa LS, Acharya A, Mohan M, Byrareddy SN (2023) Therapeutic potential of cannabis: a comprehensive review of current and future applications. Biomedicines 11(10):1\u201319. https:\/\/doi.org\/10.3390\/biomedicines11102630","journal-title":"Biomedicines"},{"issue":"1","key":"1631_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12029-025-01183-2","volume":"56","author":"PD Leiphrakpam","year":"2025","unstructured":"Leiphrakpam PD, Chowdhury S, Zhang M, Bajaj V, Dhir M, Are C (2025) Trends in the global incidence of pancreatic cancer and a brief review of its histologic and molecular subtypes. J Gastrointest Cancer 56(1):1\u201313. https:\/\/doi.org\/10.1007\/s12029-025-01183-2","journal-title":"J Gastrointest Cancer"},{"issue":"22","key":"1631_CR142","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.1111\/jcmm.16946","volume":"25","author":"Y Li","year":"2021","unstructured":"Li Y, Kong X, Xuan L, Wang Z, Huang YH (2021) Prolactin and endocrine therapy resistance in breast cancer: the next potential hope for breast cancer treatment. J Cell Mol Med 25(22):10327\u201310348. https:\/\/doi.org\/10.1111\/jcmm.16946","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1631_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42238-022-00163-8","volume":"4","author":"H Lingegowda","year":"2022","unstructured":"Lingegowda H, Williams BJ, Spiess KG, Sisnett DJ, Lomax AE, Koti M, Tayade C (2022) Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications. J Cannabis Res 4(1):1\u201313. https:\/\/doi.org\/10.1186\/s42238-022-00163-8","journal-title":"J Cannabis Res"},{"issue":"1","key":"1631_CR144","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2478\/aiht-2020-71-3302","volume":"71","author":"M Lipnik-\u0160tangelj","year":"2020","unstructured":"Lipnik-\u0160tangelj M, Razinger B (2020) A regulatory take on cannabis and cannabinoids for medicinal use in the European Union. Arh Hig Rada Toksikol 71(1):12\u201318. https:\/\/doi.org\/10.2478\/aiht-2020-71-3302","journal-title":"Arh Hig Rada Toksikol"},{"key":"1631_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1494018","author":"O Litvinova","year":"2024","unstructured":"Litvinova O, Baral B, Wochele-Thoma T, Matin M, Tzvetkov NT, Adamska O, Kami\u0144ska A, \u0141api\u0144ski M, Stolarczyk A, Atanasov AG (2024) Efficiency and safety of cannabinoid medical use: an analysis of discussions and observed trends on Instagram. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2024.1494018","journal-title":"Front Public Health"},{"issue":"13","key":"1631_CR146","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/glia.20856","volume":"57","author":"M Lorente","year":"2009","unstructured":"Lorente M, Carracedo A, Torres S, Natali F, Egia A, Hern\u00e1ndez-Tiedra S, Salazar M, Bl\u00e1zquez C, Guzm\u00e1n M, Velasco G (2009) Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. Glia 57(13):1374\u20131385. https:\/\/doi.org\/10.1002\/glia.20856","journal-title":"Glia"},{"issue":"17\u201318","key":"1631_CR147","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.lfs.2010.02.014","volume":"86","author":"AN Lozano-Ondoua","year":"2010","unstructured":"Lozano-Ondoua AN, Wright C, Vardanyan A, King T, Largent-Milnes TM, Nelson M, Jimenez-Andrade JM, Mantyh PW, Vanderah TW (2010) A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. Life Sci 86(17\u201318):646\u2013653. https:\/\/doi.org\/10.1016\/j.lfs.2010.02.014","journal-title":"Life Sci"},{"issue":"3","key":"1631_CR148","doi-asserted-by":"publisher","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","volume":"22","author":"B Lutz","year":"2020","unstructured":"Lutz B (2020) Neurobiology of cannabinoid receptor signaling. Dialogues Clin Neurosci 22(3):207\u2013222. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/blutz","journal-title":"Dialogues Clin Neurosci"},{"key":"1631_CR149","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jddst.2019.03.015","volume":"51","author":"PZ Lv","year":"2019","unstructured":"Lv PZ, Guo D, Liu M, Chen J, Guo X, Xu R, Zhang Y, Liu Q, Guo Y, Yang H (2019) Structural analysis and cytotoxicity of host-guest inclusion complexes of cannabidiol with three native cyclodextrins. J Drug Deliv Sci Technol 51:337\u2013344. https:\/\/doi.org\/10.1016\/j.jddst.2019.03.015","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"1631_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15030359","volume":"15","author":"M Malach","year":"2022","unstructured":"Malach M, Kovalchuk I, Kovalchuk O (2022) Medical cannabis in pediatric oncology: friend or foe? Pharmaceuticals (Basel) 15(3):1\u201328. https:\/\/doi.org\/10.3390\/ph15030359","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"1631_CR151","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1517\/14728222.2011.553606","volume":"15","author":"AM Malfitano","year":"2011","unstructured":"Malfitano AM, Ciaglia E, Gangemi G, Gazzerro P, Laezza C, Bifulco M (2011) Update on the endocannabinoid system as an anticancer target. Expert Opin Ther Targets 15(3):297\u2013308. https:\/\/doi.org\/10.1517\/14728222.2011.553606","journal-title":"Expert Opin Ther Targets"},{"issue":"9","key":"1631_CR152","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00432-021-03710-7","volume":"147","author":"N Mangal","year":"2021","unstructured":"Mangal N, Erridge S, Habib N, Sadanandam A, Reebye V, Sodergren MH (2021) Cannabinoids in the landscape of cancer. J Cancer Res Clin Oncol 147(9):2507\u20132534. https:\/\/doi.org\/10.1007\/s00432-021-03710-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1631_CR153","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1158\/1535-7163.Mct-09-0407","volume":"9","author":"JP Marcu","year":"2010","unstructured":"Marcu JP, Christian RT, Lau D, Zielinski AJ, Horowitz MP, Lee J, Pakdel A, Allison J, Limbad C, Moore DH, Yount GL, Desprez PY, McAllister SD (2010) Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther 9(1):180\u2013189. https:\/\/doi.org\/10.1158\/1535-7163.Mct-09-0407","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"1631_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21155409","volume":"21","author":"O Marinelli","year":"2020","unstructured":"Marinelli O, Morelli MB, Annibali D, Aguzzi C, Zeppa L, Tuyaerts S, Amantini C, Amant F, Ferretti B, Maggi F, Santoni G, Nabissi M (2020) The effects of cannabidiol and prognostic role of TRPV2 in human endometrial cancer. Int J Mol Sci 21(15):1\u201322. https:\/\/doi.org\/10.3390\/ijms21155409","journal-title":"Int J Mol Sci"},{"issue":"1-2","key":"1631_CR155","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijpharm.2015.04.054","volume":"487","author":"L Mart\u00edn-Banderas","year":"2015","unstructured":"Mart\u00edn-Banderas L, Mu\u00f1oz-Rubio I, Prados J, \u00c1lvarez-Fuentes J, Calder\u00f3n-Monta\u00f1o JM, L\u00f3pez-L\u00e1zaro M, Arias JL, Leiva MC, Holgado MA, Fern\u00e1ndez-Ar\u00e9valo M (2015) In vitro and in vivo evaluation of \u03949-tetrahidrocannabinol\/PLGA nanoparticles for cancer chemotherapy. Int J Pharm 487(1\u20132):205\u2013212. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.04.054","journal-title":"Int J Pharm"},{"issue":"2","key":"1631_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules29020473","volume":"29","author":"N Martinez Naya","year":"2024","unstructured":"Martinez Naya N, Kelly J, Corna G, Golino M, Polizio AH, Abbate A, Toldo S, Mezzaroma E (2024) An overview of cannabidiol as a multifunctional drug: pharmacokinetics and cellular effects. Molecules 29(2):1\u201325. https:\/\/doi.org\/10.3390\/molecules29020473","journal-title":"Molecules"},{"issue":"9","key":"1631_CR157","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.155","volume":"17","author":"VD Marzo","year":"2018","unstructured":"Marzo VD (2018) Corrigendum: new approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov 17(9):623\u2013639. https:\/\/doi.org\/10.1038\/nrd.2018.155","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"1631_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-025-06323-6","volume":"151","author":"SP Mathibela","year":"2025","unstructured":"Mathibela SP, Ncube KN, Lebelo MT, Steenkamp V (2025) Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology. J Cancer Res Clin Oncol 151(11):1\u201315. https:\/\/doi.org\/10.1007\/s00432-025-06323-6","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"1631_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23169423","volume":"23","author":"BRS Mboumba","year":"2022","unstructured":"Mboumba BRS, Sebastiani G, Di Marzo V, Jenabian MA, Costiniuk CT (2022) Cannabinoids and chronic liver diseases. Int J Mol Sci 23(16):1\u201324. https:\/\/doi.org\/10.3390\/ijms23169423","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1631_CR160","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","volume":"129","author":"SD McAllister","year":"2011","unstructured":"McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C, Liu Y, Debs RJ, Moore DH, Desprez P (2011) Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat 129(1):37\u201347. https:\/\/doi.org\/10.1007\/s10549-010-1177-4","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1631_CR161","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","volume":"100","author":"RJ McKallip","year":"2002","unstructured":"McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M (2002) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100(2):627\u2013634. https:\/\/doi.org\/10.1182\/blood-2002-01-0098","journal-title":"Blood"},{"issue":"6","key":"1631_CR162","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","volume":"174","author":"RJ McKallip","year":"2005","unstructured":"McKallip RJ, Nagarkatti M, Nagarkatti PS (2005) Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 174(6):3281\u20133289. https:\/\/doi.org\/10.4049\/jimmunol.174.6.3281","journal-title":"J Immunol"},{"issue":"6","key":"1631_CR163","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1080\/10428194.2021.2020776","volume":"63","author":"CM Mel\u00e9n","year":"2022","unstructured":"Mel\u00e9n CM, Merrien M, Wasik AM, Panagiotidis G, Beck O, Sonnevi K, Junl\u00e9n HR, Christensson B, Sander B, Wahlin BE (2022) Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia. Leuk Lymphoma 63(6):1387\u20131397. https:\/\/doi.org\/10.1080\/10428194.2021.2020776","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1631_CR164","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/ijc.23114","volume":"122","author":"CW Michalski","year":"2008","unstructured":"Michalski CW, Oti FE, Erkan M, Sauliunaite D, Bergmann F, Pacher P, Batkai S, M\u00fcller MW, Giese NA, Friess H, Kleeff J (2008) Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer 122(4):742\u2013750. https:\/\/doi.org\/10.1002\/ijc.23114","journal-title":"Int J Cancer"},{"key":"1631_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar SA, Stone NL, Yates AS, O\u2019Sullivan SE (2018) A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol 9:1\u201313. https:\/\/doi.org\/10.3389\/fphar.2018.01365","journal-title":"Front Pharmacol"},{"key":"1631_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.00339","volume":"10","author":"E Moreno","year":"2019","unstructured":"Moreno E, Cavic M, Krivokuca A, Casad\u00f3 V, Canela E (2019) The endocannabinoid system as a target in cancer diseases: are we there yet? Front Pharmacol 10:1\u201323. https:\/\/doi.org\/10.3389\/fphar.2019.00339","journal-title":"Front Pharmacol"},{"key":"1631_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00487","author":"C Muller","year":"2018","unstructured":"Muller C, Morales P, Reggio PH (2018) Cannabinoid ligands targeting trp channels. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2018.00487","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"1631_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15092505","volume":"15","author":"ZW Myint","year":"2023","unstructured":"Myint ZW, St Clair WH, Strup SE, Yan D, Li N, Allison DB, McLouth LE, Ellis CS, Wang P, James AC, Hensley PJ, Otto DE, Arnold SM, DiPaola RS, Kolesar JM (2023) A phase I dose escalation and expansion study of epidiolex (cannabidiol) in patients with biochemically recurrent prostate cancer. Cancers (Basel) 15(9):1\u201313. https:\/\/doi.org\/10.3390\/cancers15092505","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1631_CR169","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/carcin\/bgs328","volume":"34","author":"M Nabissi","year":"2013","unstructured":"Nabissi M, Morelli MB, Santoni M, Santoni G (2013) Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. Carcinogenesis 34(1):48\u201357. https:\/\/doi.org\/10.1093\/carcin\/bgs328","journal-title":"Carcinogenesis"},{"issue":"3","key":"1631_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-026-03380-z","volume":"27","author":"A Nagaraj","year":"2026","unstructured":"Nagaraj A, Seyfoddin A (2026) Cannabinoid oral mucosal delivery: approaches to formulation, fabrication, and permeation enhancement. AAPS PharmSciTech 27(3):1\u201321. https:\/\/doi.org\/10.1208\/s12249-026-03380-z","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"1631_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2024.50391","volume":"7","author":"MM Nayak","year":"2024","unstructured":"Nayak MM, Chai P, Catalano PJ, Pirl WF, Tulsky JA, Tung SC, Lin NU, Andrade N, Johns S, Vaz C, Hughes M, Braun IM (2024) Cannabidiol for scan-related anxiety in women with advanced breast cancer: a randomized clinical trial. JAMA Netw Open 7(12):1\u201312. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.50391","journal-title":"JAMA Netw Open"},{"key":"1631_CR172","unstructured":"New York State Department of Health (2023) licensing and certification. In: New York State Department of Health https:\/\/www.health.ny.gov\/professionals\/narcotic\/licensing_and_certification\/ Accessed 21 September 2023"},{"key":"1631_CR173","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lfs.2015.12.053","volume":"146","author":"M Nikan","year":"2016","unstructured":"Nikan M, Nabavi SM, Manayi A (2016) Ligands for cannabinoid receptors, promising anticancer agents. Life Sci 146:124\u2013130. https:\/\/doi.org\/10.1016\/j.lfs.2015.12.053","journal-title":"Life Sci"},{"issue":"1","key":"1631_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom13010162","volume":"13","author":"N Niloy","year":"2023","unstructured":"Niloy N, Hediyal TA, Vichitra C, Sonali S, Chidambaram SB, Gorantla VR, Mahalakshmi AM (2023) Effect of cannabis on memory consolidation, learning and retrieval and its current legal status in India: a review. Biomolecules 13(1):1\u201320. https:\/\/doi.org\/10.3390\/biom13010162","journal-title":"Biomolecules"},{"issue":"24","key":"1631_CR175","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1158\/0008-5472.Can-04-3136","volume":"64","author":"K Nithipatikom","year":"2004","unstructured":"Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB (2004) 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res 64(24):8826\u20138830. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3136","journal-title":"Cancer Res"},{"issue":"20","key":"1631_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20205235","volume":"20","author":"A Notaro","year":"2019","unstructured":"Notaro A, Emanuele S, Geraci F, D\u2019Anneo A, Lauricella M, Calvaruso G, Giuliano M (2019) WIN55,212\u20132-induced expression of Mir-29b1 favours the suppression of osteosarcoma cell migration in a SPARC-independent manner. Int J Mol Sci 20(20):1\u201315. https:\/\/doi.org\/10.3390\/ijms20205235","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1631_CR177","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","volume":"215","author":"SE O'Sullivan","year":"2010","unstructured":"O\u2019Sullivan SE, Kendall DA (2010) Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 215(8):611\u2013616. https:\/\/doi.org\/10.1016\/j.imbio.2009.09.007","journal-title":"Immunobiology"},{"issue":"4","key":"1631_CR178","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/or.2015.3746","volume":"33","author":"O Orellana-Serradell","year":"2015","unstructured":"Orellana-Serradell O, Poblete CE, Sanchez C, Castell\u00f3n EA, Gallegos I, Huidobro C, Llanos MN, Contreras HR (2015) Proapoptotic effect of endocannabinoids in prostate cancer cells. Oncol Rep 33(4):1599\u20131608. https:\/\/doi.org\/10.3892\/or.2015.3746","journal-title":"Oncol Rep"},{"issue":"7","key":"1631_CR179","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol 16(7):896\u2013913. https:\/\/doi.org\/10.1093\/neuonc\/nou087","journal-title":"Neuro Oncol"},{"issue":"9","key":"1631_CR180","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G (2013) Modulating the endocannabinoid system in human health and disease\u2013successes and failures. FEBS J 280(9):1918\u20131943. https:\/\/doi.org\/10.1111\/febs.12260","journal-title":"FEBS J"},{"issue":"3","key":"1631_CR181","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.gendis.2022.07.023","volume":"10","author":"H Padinharayil","year":"2023","unstructured":"Padinharayil H, Varghese J, John MC, Rajanikant GK, Wilson CM, Al-Yozbaki M, Renu K, Dewanjee S, Sanyal R, Dey A, Mukherjee AG, Wanjari UR, Gopalakrishnan A, George A (2023) Non-small cell lung carcinoma (NSCLC): implications on molecular pathology and advances in early diagnostics and therapeutics. Genes Dis 10(3):960\u2013989. https:\/\/doi.org\/10.1016\/j.gendis.2022.07.023","journal-title":"Genes Dis"},{"key":"1631_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22073680","volume":"22","author":"C Pagano","year":"2021","unstructured":"Pagano C, Navarra G, Coppola L, Bifulco M, Laezza C (2021) Molecular mechanism of cannabinoids in cancer progression. Int J Mol Sci 2:1\u201321. https:\/\/doi.org\/10.3390\/ijms22073680","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1631_CR183","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000525629","volume":"5","author":"M Palrasu","year":"2022","unstructured":"Palrasu M, Wright L, Patel M, Leech L, Branch S, Harrelson S, Khan S (2022) Perspectives on challenges in cannabis drug delivery systems: where are we? Med Cannabis Cannabinoids 5(1):102\u2013119. https:\/\/doi.org\/10.1159\/000525629","journal-title":"Med Cannabis Cannabinoids"},{"issue":"4","key":"1631_CR184","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252\u2013264. https:\/\/doi.org\/10.1038\/nrc3239","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1631_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics15112533","volume":"15","author":"C Park","year":"2023","unstructured":"Park C, Zuo J, Gil MC, L\u00f6benberg R, Lee BJ (2023) Investigation of cannabinoid acid\/cyclodextrin inclusion complex for improving physicochemical and biological performance. Pharmaceutics 15(11):1\u201321. https:\/\/doi.org\/10.3390\/pharmaceutics15112533","journal-title":"Pharmaceutics"},{"key":"1631_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2021.120943","volume":"607","author":"N Patel","year":"2021","unstructured":"Patel N, Kommineni N, Surapaneni SK, Kalvala A, Yaun X, Gebeyehu A, Arthur P, Duke LC, York SB, Bagde A, Meckes JDG, Singh M (2021) Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models. Int J Pharm 607:1\u201336. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120943","journal-title":"Int J Pharm"},{"issue":"2","key":"1631_CR187","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/adb.12531","volume":"23","author":"FJ Pavon","year":"2018","unstructured":"Pavon FJ, Serrano A, Sidhpura N, Polis I, Stouffer D, de Fonseca FR, Cravatt BF, Martin-Fardon R, Parsons LH (2018) Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens. Addict Biol 23(2):723\u2013734. https:\/\/doi.org\/10.1111\/adb.12531","journal-title":"Addict Biol"},{"issue":"4","key":"1631_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom12040491","volume":"12","author":"H Peeri","year":"2022","unstructured":"Peeri H, Koltai H (2022) Cannabis biomolecule effects on cancer cells and cancer stem cells: cytotoxic, anti-proliferative, and anti-migratory activities. Biomolecules 12(4):1\u201311. https:\/\/doi.org\/10.3390\/biom12040491","journal-title":"Biomolecules"},{"issue":"6","key":"1631_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv077","volume":"107","author":"E P\u00e9rez-G\u00f3mez","year":"2015","unstructured":"P\u00e9rez-G\u00f3mez E, Andradas C, Blasco-Benito S, Caffarel MM, Garc\u00eda-Taboada E, Villa-Morales M, Moreno E, Hamann S, Mart\u00edn-Villar E, Flores JM, Wenners A, Alkatout I, Klapper W, R\u00f6cken C, Bronsert P, Stickeler E, Staebler A, Bauer M, Arnold N, Soriano J, P\u00e9rez-Mart\u00ednez M, Meg\u00edas D, Moreno-Bueno G, Ortega-Guti\u00e9rrez S, Artola M, V\u00e1zquez-Villa H, Quintanilla M, Fern\u00e1ndez-Piqueras J, Canela EI, McCormick PJ, Guzm\u00e1n M, S\u00e1nchez C (2015) Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. J Natl Cancer Inst 107(6):1\u201349. https:\/\/doi.org\/10.1093\/jnci\/djv077","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1631_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2025.147758","volume":"329","author":"N Phothong","year":"2025","unstructured":"Phothong N, Vimolmangkang S, Napathorn SC (2025) Optimization of pH-responsive cannabidiol-loaded polyhydroxybutyrate\/cellulose acetate phthalate microparticles using response surface methodology for anticancer properties. Int J Biol Macromol 329(2):1\u201316. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147758","journal-title":"Int J Biol Macromol"},{"key":"1631_CR191","first-page":"8","volume":"10","author":"P Picardi","year":"2014","unstructured":"Picardi P, Ciaglia E, Proto M, Pisanti S (2014) Anandamide inhibits breast tumor-induced angiogenesis. Trans Med UniSa 10:8\u201312","journal-title":"Trans Med UniSa"},{"issue":"3","key":"1631_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21030787","volume":"21","author":"L Pietrovito","year":"2020","unstructured":"Pietrovito L, Iozzo M, Bacci M, Giannoni E, Chiarugi P (2020) Treatment with cannabinoids as a promising approach for impairing fibroblast activation and prostate cancer progression. Int J Mol Sci 21(3):1\u201316. https:\/\/doi.org\/10.3390\/ijms21030787","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1631_CR193","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/can.2015.29003.ebr","volume":"1","author":"D Piomelli","year":"2016","unstructured":"Piomelli D, Russo EB (2016) The cannabis sativa versus cannabis indica debate: an interview with Ethan Russo, MD. Cannabis Cannabinoid Res 1(1):44\u201346. https:\/\/doi.org\/10.1089\/can.2015.29003.ebr","journal-title":"Cannabis Cannabinoid Res"},{"issue":"20","key":"1631_CR194","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1182\/blood-2010-09-307355","volume":"117","author":"S Pisanti","year":"2011","unstructured":"Pisanti S, Picardi P, Prota L, Proto MC, Laezza C, McGuire PG, Morbidelli L, Gazzerro P, Ziche M, Das A, Bifulco M (2011) Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. Blood 117(20):5541\u20135550. https:\/\/doi.org\/10.1182\/blood-2010-09-307355","journal-title":"Blood"},{"key":"1631_CR195","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.21873\/anticanres.16269","volume":"43","author":"K Poommarapan","year":"2023","unstructured":"Poommarapan K, Rummaneethorn P, Srisubat A, Suwanpidokkul N, Leenutaphong P, Nararatwanchai T, Srihirun S, Phetchengkao W, Suriyachan K, Tancharoen S (2023) Gene profiling of cannabis-sativa-mediated apoptosis in human melanoma cells. Anticancer Res 43:1221\u20131237. https:\/\/doi.org\/10.21873\/anticanres.16269","journal-title":"Anticancer Res"},{"issue":"12","key":"1631_CR196","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1096\/fj.02-1129fje","volume":"17","author":"G Portella","year":"2003","unstructured":"Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M (2003) Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. FASEB J 17(12):1771\u20131773. https:\/\/doi.org\/10.1096\/fj.02-1129fje","journal-title":"FASEB J"},{"issue":"1","key":"1631_CR197","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1158\/1940-6207.Capr-10-0181","volume":"4","author":"A Preet","year":"2011","unstructured":"Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, Groopman JE, Ganju RK (2011) Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila) 4(1):65\u201375. https:\/\/doi.org\/10.1158\/1940-6207.Capr-10-0181","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"1631_CR198","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1096\/fj.11-198184","volume":"26","author":"R Ramer","year":"2012","unstructured":"Ramer R, Bublitz K, Freimuth N, Merkord J, Rohde H, Haustein M, Borchert P, Schmuhl E, Linnebacher M, Hinz B (2012) Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J 26(4):1535\u20131548. https:\/\/doi.org\/10.1096\/fj.11-198184","journal-title":"FASEB J"},{"issue":"2","key":"1631_CR199","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bcp.2014.06.017","volume":"91","author":"R Ramer","year":"2014","unstructured":"Ramer R, Fischer S, Haustein M, Manda K, Hinz B (2014) Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Biochem Pharmacol 91(2):202\u2013216. https:\/\/doi.org\/10.1016\/j.bcp.2014.06.017","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1631_CR200","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jnci\/djm268","volume":"100","author":"R Ramer","year":"2008","unstructured":"Ramer R, Hinz B (2008) Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 100(1):59\u201369. https:\/\/doi.org\/10.1093\/jnci\/djm268","journal-title":"J Natl Cancer Inst"},{"key":"1631_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.00430","volume":"10","author":"R Ramer","year":"2019","unstructured":"Ramer R, Schwarz R, Hinz B (2019) Modulation of the endocannabinoid system as a potential anticancer strategy. Front Pharmacol 10:1\u201317. https:\/\/doi.org\/10.3389\/fphar.2019.00430","journal-title":"Front Pharmacol"},{"issue":"22","key":"1631_CR202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13225701","volume":"13","author":"R Ramer","year":"2021","unstructured":"Ramer R, Wittig F, Hinz B (2021) The endocannabinoid system as a pharmacological target for new cancer therapies. Cancers (Basel) 13(22):1\u201328. https:\/\/doi.org\/10.3390\/cancers13225701","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1631_CR203","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0970-1591.94942","volume":"28","author":"JA Ramos","year":"2012","unstructured":"Ramos JA, Bianco FJ (2012) The role of cannabinoids in prostate cancer: basic science perspective and potential clinical applications. Indian J Urol 28(1):9\u201314. https:\/\/doi.org\/10.4103\/0970-1591.94942","journal-title":"Indian J Urol"},{"issue":"9","key":"1631_CR204","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.18632\/oncotarget.1723","volume":"5","author":"J Ravi","year":"2014","unstructured":"Ravi J, Sneh A, Shilo K, Nasser MW, Ganju RK (2014) FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF\/EGFR pathway. Oncotarget 5(9):2475\u20132486. https:\/\/doi.org\/10.18632\/oncotarget.1723","journal-title":"Oncotarget"},{"issue":"2","key":"1631_CR205","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13167-020-00203-4","volume":"11","author":"V Reddy","year":"2020","unstructured":"Reddy V, Grogan D, Ahluwalia M, Salles EL, Ahluwalia P, Khodadadi H, Alverson K, Nguyen A, Raju SP, Gaur P, Braun M, Vale FL, Costigliola V, Dhandapani K, Baban B, Vaibhav K (2020) Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. EPMA J 11(2):217\u2013250. https:\/\/doi.org\/10.1007\/s13167-020-00203-4","journal-title":"EPMA J"},{"issue":"1","key":"1631_CR206","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11864-022-01047-y","volume":"24","author":"JE Rodriguez-Almaraz","year":"2023","unstructured":"Rodriguez-Almaraz JE, Butowski N (2023) Therapeutic and supportive effects of cannabinoids in patients with brain tumors (CBD oil and cannabis). Curr Treat Options Oncol 24(1):30\u201344. https:\/\/doi.org\/10.1007\/s11864-022-01047-y","journal-title":"Curr Treat Options Oncol"},{"key":"1631_CR207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","volume":"46","author":"S Rosenthaler","year":"2014","unstructured":"Rosenthaler S, P\u00f6hn B, Kolmanz C, Huu CN, Krewenka C, Huber A, Kranner B, Rausch WD, Moldzio R (2014) Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. Neurotoxicol Teratol 46:49\u201356. https:\/\/doi.org\/10.1016\/j.ntt.2014.09.003","journal-title":"Neurotoxicol Teratol"},{"issue":"8","key":"1631_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms24087542","volume":"24","author":"G Rossi","year":"2023","unstructured":"Rossi G, Di Nisio V, Chiominto A, Cecconi S, Maccarrone M (2023) Endocannabinoid system components of the female mouse reproductive tract are modulated during reproductive aging. Int J Mol Sci 24(8):1\u201315. https:\/\/doi.org\/10.3390\/ijms24087542","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1631_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-025-02499-y","volume":"11","author":"E Rozengurt","year":"2026","unstructured":"Rozengurt E, Eibl G (2026) Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. Signal Transduct Target Ther 11(1):1\u201328. https:\/\/doi.org\/10.1038\/s41392-025-02499-y","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"1631_CR210","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00018-018-2994-6","volume":"76","author":"I Ruiz de Azua","year":"2019","unstructured":"Ruiz de Azua I, Lutz B (2019) Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues. Cell Mol Life Sci 76(7):1341\u20131363. https:\/\/doi.org\/10.1007\/s00018-018-2994-6","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"1631_CR211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14133129","volume":"14","author":"A Rupprecht","year":"2022","unstructured":"Rupprecht A, Theisen U, Wendt F, Frank M, Hinz B (2022) The combination of \u0394(9)-tetrahydrocannabinol and cannabidiol suppresses mitochondrial respiration of human glioblastoma cells via downregulation of specific respiratory chain proteins. Cancers (Basel) 14(13):1\u201322. https:\/\/doi.org\/10.3390\/cancers14133129","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1631_CR212","doi-asserted-by":"publisher","first-page":"272","DOI":"10.18632\/oncoscience.33","volume":"1","author":"S Sailler","year":"2014","unstructured":"Sailler S, Schmitz K, J\u00e4ger E, Ferreiros N, Wicker S, Zschiebsch K, Pickert G, Geisslinger G, Walter C, Tegeder I, L\u00f6tsch J (2014) Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans. Oncoscience 1(4):272\u2013282. https:\/\/doi.org\/10.18632\/oncoscience.33","journal-title":"Oncoscience"},{"issue":"1","key":"1631_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52793\/JCTR.2023.4(1)-32","volume":"4","author":"LL Salazar","year":"2024","unstructured":"Salazar LL, Gil-Qui\u00f1ones S, Bonnici L, Parra DT (2024) The impact of cannabinoids on breast cancer cell lines: a meta-analysis and systematic review of antitumoral effects. J Cancer Ther Res 4(1):1\u201317. https:\/\/doi.org\/10.52793\/JCTR.2023.4(1)-32","journal-title":"J Cancer Ther Res"},{"issue":"5","key":"1631_CR214","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/jci37948","volume":"119","author":"M Salazar","year":"2009","unstructured":"Salazar M, Carracedo A, Salanueva IJ, Hern\u00e1ndez-Tiedra S, Lorente M, Egia A, V\u00e1zquez P, Bl\u00e1zquez C, Torres S, Garc\u00eda S, Nowak J, Fimia GM, Piacentini M, Cecconi F, Pandolfi PP, Gonz\u00e1lez-Feria L, Iovanna JL, Guzm\u00e1n M, Boya P, Velasco G (2009) Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 119(5):1359\u20131372. https:\/\/doi.org\/10.1172\/jci37948","journal-title":"J Clin Invest"},{"key":"1631_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/or.2025.1573797","author":"KCR Salum","year":"2025","unstructured":"Salum KCR, Miranda GBA, Dias AL, Carneiro JRI, Bozza PT, da Fonseca ACP, Silva T (2025) The endocannabinoid system in cancer biology: a mini-review of mechanisms and therapeutic potential. Oncol Rev. https:\/\/doi.org\/10.3389\/or.2025.1573797","journal-title":"Oncol Rev"},{"issue":"5","key":"1631_CR216","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ijc.24483","volume":"125","author":"A Santoro","year":"2009","unstructured":"Santoro A, Pisanti S, Grimaldi C, Izzo AA, Borrelli F, Proto MC, Malfitano AM, Gazzerro P, Laezza C, Bifulco M (2009) Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer 125(5):996\u20131003. https:\/\/doi.org\/10.1002\/ijc.24483","journal-title":"Int J Cancer"},{"issue":"2","key":"1631_CR217","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","volume":"12","author":"P Sarantis","year":"2020","unstructured":"Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV (2020) Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 12(2):173\u2013181. https:\/\/doi.org\/10.4251\/wjgo.v12.i2.173","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"1631_CR218","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1158\/0008-5472.Can-04-3410","volume":"65","author":"S Sarfaraz","year":"2005","unstructured":"Sarfaraz S, Afaq F, Adhami VM, Mukhtar H (2005) Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 65(5):1635\u20131641. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3410","journal-title":"Cancer Res"},{"key":"1631_CR219","doi-asserted-by":"publisher","unstructured":"Sarsembayeva A, Kienzl M, Gruden E, Ristic D, Maitz K, Valadez-Cosmes P, Santiso A, Hasenoehrl C, Brcic L, Lindenmann J, Kargl J, Schicho R (2022) Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8(+) T and NK cells. Front Immunol 13:1\u201317. https:\/\/doi.org\/10.3389\/fimmu.2022.997115","DOI":"10.3389\/fimmu.2022.997115"},{"issue":"3","key":"1631_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25030652","volume":"25","author":"C Scheau","year":"2020","unstructured":"Scheau C, Badarau IA, Mihai LG, Scheau AE, Costache DO, Constantin C, Calina D, Caruntu C, Costache RS, Caruntu A (2020) Cannabinoids in the pathophysiology of skin inflammation. Molecules 25(3):1\u201323. https:\/\/doi.org\/10.3390\/molecules25030652","journal-title":"Molecules"},{"key":"1631_CR221","doi-asserted-by":"publisher","unstructured":"Schleider LBL, Mechoulam R, Lederman V, Hilou M, Lencovsky O, Betzalel O, Shbiro L, Novack V (2018) Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med 49:37\u201343. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.023","DOI":"10.1016\/j.ejim.2018.01.023"},{"issue":"20","key":"1631_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25204682","volume":"25","author":"R Schoeman","year":"2020","unstructured":"Schoeman R, Beukes N, Frost C (2020) Cannabinoid combination induces cytoplasmic vacuolation in MCF-7 breast cancer cells. Molecules 25(20):1\u201321. https:\/\/doi.org\/10.3390\/molecules25204682","journal-title":"Molecules"},{"issue":"1","key":"1631_CR223","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/03602532.2018.1428344","volume":"50","author":"R Schwarz","year":"2018","unstructured":"Schwarz R, Ramer R, Hinz B (2018) Targeting the endocannabinoid system as a potential anticancer approach. Drug Metab Rev 50(1):26\u201353. https:\/\/doi.org\/10.1080\/03602532.2018.1428344","journal-title":"Drug Metab Rev"},{"key":"1631_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.697832","author":"F Shangguan","year":"2021","unstructured":"Shangguan F, Zhou H, Ma N, Wu S, Huang H, Jin G, Wu S, Hong W, Zhuang W, Xia H, Lan L (2021) A novel mechanism of cannabidiol in suppressing hepatocellular carcinoma by inducing GSDME dependent pyroptosis. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.697832","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"1631_CR225","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4236\/pp.2014.58091","volume":"5","author":"M Sharma","year":"2014","unstructured":"Sharma M, Hudson JB, Adomat H, Guns E, Cox ME (2014) In vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines. Pharmacol Pharm 5(8):806\u2013820. https:\/\/doi.org\/10.4236\/pp.2014.58091","journal-title":"Pharmacol Pharm"},{"issue":"2","key":"1631_CR226","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.cgt.7701101","volume":"15","author":"Y Shi","year":"2008","unstructured":"Shi Y, Zou M, Baitei EY, Alzahrani AS, Parhar RS, Al-Makhalafi Z, Al-Mohanna FA (2008) Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma. Cancer Gene Ther 15(2):101\u2013107. https:\/\/doi.org\/10.1038\/sj.cgt.7701101","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"1631_CR227","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023) Colorectal cancer statistics, 2023. CA Cancer J Clin 73(3):233\u2013254. https:\/\/doi.org\/10.3322\/caac.21772","journal-title":"CA Cancer J Clin"},{"key":"1631_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2022.115261","volume":"205","author":"M Simard","year":"2022","unstructured":"Simard M, Archambault AS, Lavoie JPC, Dumais \u00c9, Di Marzo V, Flamand N (2022) Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families. Biochem Pharmacol 205:1\u201314. https:\/\/doi.org\/10.1016\/j.bcp.2022.115261","journal-title":"Biochem Pharmacol"},{"key":"1631_CR229","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jss.2018.08.055","volume":"235","author":"E Simmerman","year":"2019","unstructured":"Simmerman E, Qin X, Yu JC, Baban B (2019) Cannabinoids as a potential new and novel treatment for melanoma: a pilot study in a murine model. J Surg Res 235:210\u2013215. https:\/\/doi.org\/10.1016\/j.jss.2018.08.055","journal-title":"J Surg Res"},{"issue":"1","key":"1631_CR230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2014.566","volume":"6","author":"E Singer","year":"2015","unstructured":"Singer E, Judkins J, Salomonis N, Matlaf L, Soteropoulos P, McAllister S, Soroceanu L (2015) Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death Dis 6(1):1\u201311. https:\/\/doi.org\/10.1038\/cddis.2014.566","journal-title":"Cell Death Dis"},{"key":"1631_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lansea.2025.100546","volume":"34","author":"K Singh","year":"2025","unstructured":"Singh K, Grover A, Dhanasekaran K (2025) Unveiling the cancer epidemic in India: a glimpse into GLOBOCAN 2022 and past patterns. Lancet Reg Health Southeast Asia 34:1\u201311. https:\/\/doi.org\/10.1016\/j.lansea.2025.100546","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"16","key":"1631_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13164107","volume":"13","author":"K Singh","year":"2021","unstructured":"Singh K, Nassar N, Bachari A, Schanknecht E, Telukutla S, Zomer R, Piva TJ, Mantri N (2021) The pathophysiology and the therapeutic potential of cannabinoids in prostate cancer. Cancers (Basel) 13(16):1\u201318. https:\/\/doi.org\/10.3390\/cancers13164107","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1631_CR233","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1159\/000356446","volume":"6","author":"Y Singh","year":"2013","unstructured":"Singh Y, Bali C (2013) Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation. Case Rep Oncol 6(3):585\u2013592. https:\/\/doi.org\/10.1159\/000356446","journal-title":"Case Rep Oncol"},{"issue":"1","key":"1631_CR234","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22010263","volume":"22","author":"P \u015aledzi\u0144ski","year":"2020","unstructured":"\u015aledzi\u0144ski P, Nowak-Terpi\u0142owska A, Zeyland J (2020) Cannabinoids in medicine: cancer, immunity, and microbial diseases. Int J Mol Sci 22(1):1\u201321. https:\/\/doi.org\/10.3390\/ijms22010263","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1631_CR235","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cam4.1312","volume":"7","author":"P \u015aledzi\u0144ski","year":"2018","unstructured":"\u015aledzi\u0144ski P, Zeyland J, S\u0142omski R, Nowak A (2018) The current state and future perspectives of cannabinoids in cancer biology. Cancer Med 7(3):765\u2013775. https:\/\/doi.org\/10.1002\/cam4.1312","journal-title":"Cancer Med"},{"key":"1631_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2022.1055481","volume":"13","author":"RT Smith","year":"2022","unstructured":"Smith RT, Gruber SA (2022) Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions. Front Psychiatry 13:1\u20137. https:\/\/doi.org\/10.3389\/fpsyt.2022.1055481","journal-title":"Front Psychiatry"},{"key":"1631_CR237","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00720","author":"K Soderstrom","year":"2017","unstructured":"Soderstrom K, Soliman E, Van Dross R (2017) Cannabinoids modulate neuronal activity and cancer by CB1 and CB2 receptor-independent mechanisms. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00720","journal-title":"Front Pharmacol"},{"issue":"11","key":"1631_CR238","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/mc.22429","volume":"55","author":"E Soliman","year":"2016","unstructured":"Soliman E, Van Dross R (2016) Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: receptor-independent endocannabinoid signaling. Mol Carcinog 55(11):1807\u20131821. https:\/\/doi.org\/10.1002\/mc.22429","journal-title":"Mol Carcinog"},{"issue":"10","key":"1631_CR239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0076918","volume":"8","author":"M Solinas","year":"2013","unstructured":"Solinas M, Massi P, Cinquina V, Valenti M, Bolognini D, Gariboldi M, Monti E, Rubino T, Parolaro D (2013) Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS ONE 8(10):1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0076918","journal-title":"PLoS ONE"},{"issue":"13","key":"1631_CR240","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","volume":"81","author":"B Stella","year":"2021","unstructured":"Stella B, Baratta F, Della Pepa C, Arpicco S, Gastaldi D, Dosio F (2021) Cannabinoid formulations and delivery systems: current and future options to treat pain. Drugs 81(13):1513\u20131557. https:\/\/doi.org\/10.1007\/s40265-021-01579-x","journal-title":"Drugs"},{"issue":"10","key":"1631_CR241","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10102509","volume":"10","author":"R Sugiura","year":"2021","unstructured":"Sugiura R, Satoh R, Takasaki T (2021) ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells 10(10):1\u201329. https:\/\/doi.org\/10.3390\/cells10102509","journal-title":"Cells"},{"key":"1631_CR242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2025.123527","volume":"474","author":"YA Tabi","year":"2025","unstructured":"Tabi YA, Meyer EC (2025) Differential impact of cannabis abuse on neurological disorders. J Neurol Sci 474:1\u20139. https:\/\/doi.org\/10.1016\/j.jns.2025.123527","journal-title":"J Neurol Sci"},{"issue":"4","key":"1631_CR243","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","volume":"24","author":"T Taha","year":"2019","unstructured":"Taha T, Meiri D, Talhamy S, Wollner M, Peer A, Bar-Sela G (2019) Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies. Oncologist 24(4):549\u2013554. https:\/\/doi.org\/10.1634\/theoncologist.2018-0383","journal-title":"Oncologist"},{"issue":"2","key":"1631_CR244","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11419-022-00655-5","volume":"41","author":"S Takeda","year":"2023","unstructured":"Takeda S, Hirao-Suzuki M, Aramaki H, Watanabe K (2023) \u03949-Tetrahydrocannabinol stimulation of estrogen receptor-positive MCF-7 breast cancer cell migration: interfering interaction with the estrogenic milieu. Forensic Toxicol 41(2):287\u2013293. https:\/\/doi.org\/10.1007\/s11419-022-00655-5","journal-title":"Forensic Toxicol"},{"issue":"1\u20132","key":"1631_CR245","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tox.2009.01.024","volume":"259","author":"S Takeda","year":"2009","unstructured":"Takeda S, Yamamoto I, Watanabe K (2009) Modulation of delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase. Toxicology 259(1\u20132):25\u201332. https:\/\/doi.org\/10.1016\/j.tox.2009.01.024","journal-title":"Toxicology"},{"issue":"1","key":"1631_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13010037","volume":"13","author":"AH Taylor","year":"2020","unstructured":"Taylor AH, Tortolani D, Ayakannu T, Konje JC, Maccarrone M (2020) (Endo)Cannabinoids and gynaecological cancers. Cancers (Basel) 13(1):1\u201322. https:\/\/doi.org\/10.3390\/cancers13010037","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1631_CR247","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2010.09.073","volume":"650","author":"D Thapa","year":"2011","unstructured":"Thapa D, Lee JS, Heo SW, Lee YR, Kang KW, Kwak M, Choi HG, Kim J (2011) Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis. Eur J Pharmacol 650(1):64\u201371. https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.073","journal-title":"Eur J Pharmacol"},{"key":"1631_CR248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10102492","volume":"10","author":"IM Tudorancea","year":"2022","unstructured":"Tudorancea IM, Ciorpac M, Stanciu GD, Caratasu C, S\u0103c\u0103rescu A, Ignat B, Burlui A, Rezus E, Creang\u0103 I, Alexa-Stratulat T, Tudorancea I, Tamba BI (2022) The therapeutic potential of the endocannabinoid system in age-related diseases. Biomedicines 10:1\u201349. https:\/\/doi.org\/10.3390\/biomedicines10102492","journal-title":"Biomedicines"},{"issue":"11","key":"1631_CR249","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4149\/bll_2022_130","volume":"123","author":"NH Turgut","year":"2022","unstructured":"Turgut NH, Armagan G, Kasapligil G, Erdogan MA (2022) Anti-cancer effects of selective cannabinoid agonists in pancreatic and breast cancer cells. Bratisl Lek Listy 123(11):813\u2013821. https:\/\/doi.org\/10.4149\/bll_2022_130","journal-title":"Bratisl Lek Listy"},{"issue":"8","key":"1631_CR250","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41416-021-01259-3","volume":"124","author":"C Twelves","year":"2021","unstructured":"Twelves C, Sabel M, Checketts D, Miller S, Tayo B, Jove M, Brazil L, Short SC (2021) A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma. Br J Cancer 124(8):1379\u20131387. https:\/\/doi.org\/10.1038\/s41416-021-01259-3","journal-title":"Br J Cancer"},{"key":"1631_CR251","unstructured":"U.S. Customs and Border Protection (2019) Did you know... marijuana was once a legal cross-border import? In: U.S. Customs and Border Protection https:\/\/www.cbp.gov\/about\/history\/did-you-know\/marijuana Accessed 9 September 2023"},{"key":"1631_CR252","unstructured":"U.S. Department of Agriculture (2018) Agriculture improvement act of 2018: highlights and implications. In: U.S. Department of Agriculture https:\/\/www.ers.usda.gov\/agriculture-improvement-act-of-2018-highlights-and-implications\/ Accessed 20 september 2019"},{"key":"1631_CR253","unstructured":"U.S. Drug Enforcement Administration (2021) DEA continues to prioritize efforts to expand access to marijuana for research in the United States. In: United States Drug Enforcement Administration. https:\/\/www.dea.gov\/stories\/2021\/2021-05\/2021-05-14\/dea-continues-prioritize-efforts-expand-access-marijuana-research Accessed 21 September 2023"},{"key":"1631_CR254","unstructured":"U.S. Supreme Court (1969) Leary v. United States, 395 U.S. 6 (1969) In: U.S. Supreme Court. https:\/\/supreme.justia.com\/cases\/federal\/us\/395\/6\/ Accessed 20 September 2023"},{"issue":"8-9","key":"1631_CR255","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.lfs.2012.09.025","volume":"92","author":"R Van Dross","year":"2013","unstructured":"Van Dross R, Soliman E, Jha S, Johnson T, Mukhopadhyay S (2013) Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth. Life Sci 92(8\u20139):463\u2013466. https:\/\/doi.org\/10.1016\/j.lfs.2012.09.025","journal-title":"Life Sci"},{"issue":"7","key":"1631_CR256","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/cdd.2011.32","volume":"18","author":"D Vara","year":"2011","unstructured":"Vara D, Salazar M, Olea-Herrero N, Guzm\u00e1n M, Velasco G, D\u00edaz-Laviada I (2011) Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 18(7):1099\u20131111. https:\/\/doi.org\/10.1038\/cdd.2011.32","journal-title":"Cell Death Differ"},{"issue":"16","key":"1631_CR257","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15164038","volume":"15","author":"L Vecera","year":"2023","unstructured":"Vecera L, Prasil P, Srovnal J, Berta E, Vidlarova M, Gabrhelik T, Kourilova P, Lovecek M, Skalicky P, Skarda J, Kala Z, Michalek P, Hajduch M (2023) Morphine analgesia, cannabinoid receptor 2, and opioid growth factor receptor cancer tissue expression improve survival after pancreatic cancer surgery. Cancers (Basel) 15(16):1\u201314. https:\/\/doi.org\/10.3390\/cancers15164038","journal-title":"Cancers (Basel)"},{"key":"1631_CR258","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.pnpbp.2015.05.010","volume":"64","author":"G Velasco","year":"2016","unstructured":"Velasco G, Hern\u00e1ndez-Tiedra S, D\u00e1vila D, Lorente M (2016a) The use of cannabinoids as anticancer agents. Prog Neuropsychopharmacol Biol Psychiatry 64:259\u2013266. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.05.010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"1631_CR259","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3747\/co.23.3080","volume":"23","author":"G Velasco","year":"2016","unstructured":"Velasco G, S\u00e1nchez C, Guzm\u00e1n M (2016b) Anticancer mechanisms of cannabinoids. Curr Oncol 23(2):23\u201332. https:\/\/doi.org\/10.3747\/co.23.3080","journal-title":"Curr Oncol"},{"issue":"12","key":"1631_CR260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10123000","volume":"10","author":"B Vuic","year":"2022","unstructured":"Vuic B, Milos T, Tudor L, Konjevod M, Perkovic MN, Jembrek MJ, Erjavec GN, Strac DS (2022) Cannabinoid CB2 receptors in neurodegenerative proteinopathies: new insights and therapeutic potential. Biomedicines 10(12):1\u201331. https:\/\/doi.org\/10.3390\/biomedicines10123000","journal-title":"Biomedicines"},{"key":"1631_CR261","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/scipharm94020041","volume":"94","author":"L Vyshnevska","year":"2026","unstructured":"Vyshnevska L, Yaromiy M, Pestun I, Georgiev KD, Slavov IZ, Koshovyi O (2026) Active pharmaceutical ingredients in medical cannabis: manufacturer profiling, standardization challenges, and technological compatibility. Sci Pharm 94:1\u201321. https:\/\/doi.org\/10.3390\/scipharm94020041","journal-title":"Sci Pharm"},{"key":"1631_CR262","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DDDT.S597740","volume":"20","author":"CY Wang","year":"2026","unstructured":"Wang CY, Tan JX, Chen LL, Li QZ, Liu J, He X, Qin QZ, Deng T, Ruan GT, Gong YZ (2026) Cannabidiol-induced tumor cell death: molecular mechanisms and translational perspectives in cancer therapy. Drug des Devel Ther 20:1\u201313. https:\/\/doi.org\/10.2147\/DDDT.S597740","journal-title":"Drug des Devel Ther"},{"issue":"15","key":"1631_CR263","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.Can-08-0896","volume":"68","author":"D Wang","year":"2008","unstructured":"Wang D, Wang H, Ning W, Backlund MG, Dey SK, DuBois RN (2008) Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68(15):6468\u20136476. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-0896","journal-title":"Cancer Res"},{"issue":"21","key":"1631_CR264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu15214622","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang J, Ossemond J, Le Gouar Y, Boissel F, Dupont D, P\u00e9drono F (2023) Effect of docosahexaenoic acid encapsulation with whey proteins on rat growth and tissue endocannabinoid profile. Nutrients 15(21):1\u201318. https:\/\/doi.org\/10.3390\/nu15214622","journal-title":"Nutrients"},{"issue":"12","key":"1631_CR265","doi-asserted-by":"publisher","first-page":"15047","DOI":"10.18632\/oncotarget.7592","volume":"7","author":"K Winkler","year":"2016","unstructured":"Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B (2016) Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells. Oncotarget 7(12):15047\u201315064. https:\/\/doi.org\/10.18632\/oncotarget.7592","journal-title":"Oncotarget"},{"key":"1631_CR266","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25020810","volume":"25","author":"F Wittig","year":"2024","unstructured":"Wittig F, Koch F, Pannenberg L, Bekeschus S, Ramer R, Hinz B (2024) \u03b2-caryophyllene inhibits endothelial tube formation by modulating the secretome of hypoxic lung cancer cells\u2014possible role of vegf downregulation. Int J Mol Sci 25:1\u201316. https:\/\/doi.org\/10.3390\/ijms25020810","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1631_CR267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15072119","volume":"15","author":"HJ Woerdenbag","year":"2023","unstructured":"Woerdenbag HJ, Olinga P, Kok EA, Brugman DAP, van Ark UF, Ramcharan AS, Lebbink PW, Hoogwater FJH, Knapen DG, de Groot DJA, Nijkamp MW (2023) Potential, limitations and risks of cannabis-derived products in cancer treatment. Cancers (Basel) 15(7):1\u201325. https:\/\/doi.org\/10.3390\/cancers15072119","journal-title":"Cancers (Basel)"},{"key":"1631_CR268","volume-title":"WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants","author":"World Health Organization","year":"2003","unstructured":"World Health Organization (2003) WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. World Health Organization"},{"issue":"5","key":"1631_CR269","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1471-4159.2011.07625.x","volume":"120","author":"X Wu","year":"2012","unstructured":"Wu X, Han L, Zhang X, Li L, Jiang C, Qiu Y, Huang R, Xie B, Lin Z, Ren J, Fu J (2012) Alteration of endocannabinoid system in human gliomas. J Neurochem 120(5):842\u2013849. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07625.x","journal-title":"J Neurochem"},{"key":"1631_CR270","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/ol.2012.751","volume":"4","author":"C Xie","year":"2012","unstructured":"Xie C, Liu G, Liu J, Huang Z, Wang F, Lei X, Wu X, Huang S, Zhong D, Xu X (2012) Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells. Oncol Lett 4:403\u2013407. https:\/\/doi.org\/10.3892\/ol.2012.751","journal-title":"Oncol Lett"},{"issue":"1","key":"1631_CR271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-00918-y","volume":"7","author":"X Xiong","year":"2022","unstructured":"Xiong X, Chen S, Shen J, You H, Yang H, Yan C, Fang Z, Zhang J, Cai X, Dong X, Kang T, Li W, Zhou P (2022) Cannabis suppresses antitumor immunity by inhibiting JAK\/STAT signaling in T cells through CNR2. Signal Transduct Target Ther 7(1):1\u201313. https:\/\/doi.org\/10.1038\/s41392-022-00918-y","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1631_CR272","first-page":"1188","volume":"14","author":"F Xu","year":"2022","unstructured":"Xu F, Sun G, Peng Z, Liu J, Li Z, Yan J (2022) Cannabidiol promotes apoptosis of osteosarcoma cells in vitro and in vivo by activating the SP1-CBX2 axis. Am J Transl Res 14(2):1188\u20131203","journal-title":"Am J Transl Res"},{"key":"1631_CR273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2019.109080","volume":"117","author":"S Xu","year":"2019","unstructured":"Xu S, Ma H, Bo Y, Shao M (2019) The oncogenic role of CB2 in the progression of non-small-cell lung cancer. Biomed Pharmacother 117:1\u20136. https:\/\/doi.org\/10.1016\/j.biopha.2019.109080","journal-title":"Biomed Pharmacother"},{"issue":"21","key":"1631_CR274","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21218035","volume":"21","author":"Y Yang","year":"2020","unstructured":"Yang Y, Huynh N, Dumesny C, Wang K, He H, Nikfarjam M (2020) Cannabinoids inhibited pancreatic cancer via P-21 activated kinase 1 mediated pathway. Int J Mol Sci 21(21):1\u201311. https:\/\/doi.org\/10.3390\/ijms21218035","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1631_CR275","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2022.54752","volume":"6","author":"CA Zamarripa","year":"2023","unstructured":"Zamarripa CA, Spindle TR, Surujunarain R et al (2023) Assessment of orally administered \u03949-tetrahydrocannabinol when coadministered with cannabidiol on \u03949-tetrahydrocannabinol pharmacokinetics and pharmacodynamics in healthy adults: a randomized clinical trial. JAMA Netw Open 6(2):1\u201315. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54752","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1631_CR276","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1097\/j.pain.0000000000001278","volume":"159","author":"H Zhang","year":"2018","unstructured":"Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW (2018a) Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain 159(9):1814\u20131823. https:\/\/doi.org\/10.1097\/j.pain.0000000000001278","journal-title":"Pain"},{"issue":"10","key":"1631_CR277","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2022-069908","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang J, Cai D, Hong S (2023) Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study. BMJ Open 13(10):1\u20138. https:\/\/doi.org\/10.1136\/bmjopen-2022-069908","journal-title":"BMJ Open"},{"key":"1631_CR278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep35784","volume":"6","author":"J Zhang","year":"2016","unstructured":"Zhang J, Liu Z, Lian Z, Liao R, Chen Y, Qin Y, Wang J, Jiang Q, Wang X, Gong J (2016) Monoacylglycerol lipase: a novel potential therapeutic target and prognostic indicator for hepatocellular carcinoma. Sci Rep 6:1\u201313. https:\/\/doi.org\/10.1038\/srep35784","journal-title":"Sci Rep"},{"key":"1631_CR279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2024.1359069","volume":"14","author":"R Zhang","year":"2024","unstructured":"Zhang R, Yao Y, Gao H, Hu X (2024) Mechanisms of angiogenesis in tumour. Front Oncol 14:1\u201315. https:\/\/doi.org\/10.3389\/fonc.2024.1359069","journal-title":"Front Oncol"},{"issue":"1","key":"1631_CR280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-07361-3","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang X, Li Y, Yan C, Ma L, Yu M, Yang Y, Lin S, Zhao R, Peng L (2025) Global trends in testicular and prostate cancer among adolescents and young adult males aged 15\u201349 years, 1990\u20132021: insights from the GBD study. Sci Rep 15(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-025-07361-3","journal-title":"Sci Rep"},{"issue":"8","key":"1631_CR281","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom9080302","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, Qin Y, Pan Z, Li M, Liu X, Chen X, Qu G, Zhou L, Xu M, Zheng Q, Li D (2019) Cannabidiol induces cell cycle arrest and cell apoptosis in human gastric cancer SGC-7901 cells. Biomolecules 9(8):1\u201317. https:\/\/doi.org\/10.3390\/biom9080302","journal-title":"Biomolecules"},{"issue":"6","key":"1631_CR282","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.3892\/ol.2018.8407","volume":"15","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zheng W, Shen K, Shen W (2018b) \u22069-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer. Oncol Lett 15(6):8527\u20138535. https:\/\/doi.org\/10.3892\/ol.2018.8407","journal-title":"Oncol Lett"},{"issue":"10","key":"1631_CR283","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.Can-07-6594","volume":"68","author":"D Zheng","year":"2008","unstructured":"Zheng D, Bode AM, Zhao Q, Cho Y, Zhu F, Ma W, Dong Z (2008) The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development. Cancer Res 68(10):3992\u20133998. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-6594","journal-title":"Cancer Res"},{"issue":"1","key":"1631_CR284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-97523-0","volume":"15","author":"T Zou","year":"2025","unstructured":"Zou T, Zhang R, Hu L, Yang G, Chen X, Wang M, Cheng T, Nie S, Liu L, Hong S (2025) Uncovering mechanism of hepatotoxicity diseases caused by tetrahydrocannabinol based on novel network toxicology and experimental verification. Sci Rep 15(1):1\u201314. https:\/\/doi.org\/10.1038\/s41598-025-97523-0","journal-title":"Sci Rep"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-026-01631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-026-01631-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-026-01631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:02:34Z","timestamp":1792684954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-026-01631-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":284,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1631"],"URL":"https:\/\/doi.org\/10.1007\/s12272-026-01631-y","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Chun KS is the Associate Editor of this journal, Archives of Pharmacal Research. However, his position did not influence the editorial decision or the peer review process of this manuscript. Any other authors declared no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}